ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000458.1|Viomycin_1 # 667 # 6786 # 1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=15bp;gc_cont=0.723	BGC0000458.1|Viomycin_1 	667	6786	+	Loose	1000	141.354	almE	31.49	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGCTGGAACGTGATCCGGAGCTGGTCGTCGCACTGCTCGGCGTGCTGAAGGCCGGCGGAGCCTTCGTGCCCGTCGACCCGACGTACCCGGCGGCGCGGATCCGCCACATGCTGGACGACTCCGGGGCGCGGGCCGTCCTGCTGCGCCAGGAGCTGCGGGACCGGCTGCCCGAGGACCTGCGCGACGGGACGGGACAGGTGGCGGTCGTACCGGTGGGCGCGGAGAGCGGGGCCGGGACGTCTACGCGCCGGCCGGTCACGCCGGTCGAGCAGGAGCCACGGCCCGAGCGTCTGGCCTACATCGTCTACACCTCGGGCTCCACCGGTCTGCCCAAGGGTGTGATGGTCGAGCACCGTGGCATCGTCAGCTATCTGCTGGGCATGCTGGAGCACTTCCCGATGGGGCCGCGCGACCGCATGCTGCAGGTCACGTCGCTCTCCTTCGACGTCTCCGTGTACGAGATCTTCCTGCCGCTGCTGACCGGCGGCGCCACCGTGCTCCCCCGCTCGGGCAGCCATACGGACGCCGCCTACCTGAGCGGGCTGATAGCCGAGCACGGCGTGACGTCCTTCCACATGGTGCCCTCACTGCTGCGGACCTTCGTGGACGGGCTCGATCCCCGGCAGTGCGCCGGGCTGCGCCGGATCTTCGTCAGCGGAGAGGCACTCGACACCACGCTGGTGGTCGACGTGCACGACCGCCTCCCGTGCGACGTGGTGAACCTGTACGGAGCGACCGAGGTCTCCGTCGACTCCACGTGGTGGACGGCGCCCCGGGACCTGCCGGACGCACCGGTGCTGGTCGGCCGTCCCATGGCCGGCGCCACCGCGTACGTCCTGGACGACGAGATGAGGCGACTGGCCCCGAACGAGGTGGGCGAGGTCTATCTGGGCGGGGCCAGCGTGACCCGGGGCTACCACGGGCGGGCGGCCCTGACCGCGCAGCGCTTCCTGCCCGACCCGTACGGACCTCCCGGGAGCCGGCTGTACCGCACCGGTGACCTCGGCCGGGTCGAGGACAACGGAGAGCTGCGGCTGCTGGGGCGTATCGACCACCAGGTGAAGCTGCACGGCCGACGGATCGAACCCGGTGAGATCGAGGCGGCGATGACGGCCCATCCGCACGTCTCCCTGGCCGCCGCCGTCCCTGCGGGCGCAGGCGCTGGGGCGACCCTGACCGGATTCTTCACCGGCGCGGAAGCCGACGCCGAGGAGCTGCGCGGGTTCCTCGCACAGCGGCTGCCCGCCGCGCTCGTCCCCTCCCGGCTGGTCGCACTGGACACGCTCCCCCTGTCCCCCAACGGCAAGATCGACCGGAACGCACTGGCCGACATCGCCGCGCGGCAGGACCTCGCCGCGGTACCGCCGGCACCCGAACACACCGACCCCGTCCTACGCGCCGTCCTCGACGCCACAGCGGACGTCCTGGGCGGAACACCTGTCGCCCCGCACGAGAACTTCTTCGACAAGGGCGGCAACTCCCTGCACGCGACCCGGCTCGTGGCCAAGCTGCGCTCGGCCCTGGACACGGCGATCGGCGTCCGCACGGTCTTCGAACACCAGACCCCGGCCCAACTGGCCGACGCACTGCGCGTCACGCTCGACGACGCCCCGGACAGTGGTGCGCGGGGCACCGCGGAAGGCGAGCTGTCCGCCGCCCAGCACCGTATGTGGCTGCTGGCGCAGATCTCCGAGACCCCCGCCGAGTACGCCATCACTCTCGCCCTCCACCTCGCGGGCGCCCTGGACACCGAGGCGCTCGGCTGGGCCGTCGACGCGGTGGTGCGGCGGCACGACTCCCTGCGATCGTGCTTCCCCGACCGGGACGGCACTCCCGTGCGGGCCGAGGTGCCGGCCGAGGCCTTACGGCTGATCCATGCACCGCCGGAGCCGGGCGGCGACCCGGACGAGGTGGTACGGCGAGTGGTCGCCGAAGAGACGGCCGGTCTCGACCTGGTGGCCGGGCCCCTGTTCCGGCCGGTACTGGTGCCGCTCGGCGCCGAGGAGTACCTGCTGGTGATCGTGCTCCACCACATCGTGGCGGACGGCTGGTCGACCGAGGTGCTGCTGGAGGACATCGCCGCGCACTACCGGGCCCGGACGGGCGGGGAAGCCGTACCCGGGCGTCCGGTCGTCAGCTACCGGCGCTACGTGGACATCGAGCGCCGCAACGAGCGCGACGGCGTCACCGACCGGGATCTGGAGTACTTCACCACCGAGTTGCACGGCATCCCCGAGGAGGTGACCCTGCCCCTGGACCGGCCCCGGCCCGCACAACGCACCGGGCGCGGCGCGACCCTCCGGCCGGCGTTCGGACCGCGCGGGGCCGACGCCGTTCGTCGGCTCGCCGCCGCGCACCGCACAACGCCGTTCGTGGTCCTGCTCGCCGGTCTGAGCACCCTTGTGCACCGCGCGGGCGGCCACGAGGACGTGGTGATCGGCAGTGCGGTCGCCGGGCGCTTCGACGCCGAGCTGGACGACCTCGTGGGCCTGTGCCTCAACTCGGTGGCGTTGCGCTGGCCGGTCGGTCCCACCACTGCCTTCGCCACGGTGGTGGAGCGCGCCGAGCGAAGCCTGCTCGACGCCATGGACCACTCCGCCGTGCCCTTCGCCCGGGTCGTCGAGAAGCTGGGCGTGCGCCGCGACGCGCGCCGTACCCCCGTCTTCCAGGTCATCGCTCTGTACGACGACTTCCCCGACAGCCCGGACCTGCCGGGCCTGTCCGTGCGCGCCCTGGAGACGGACGACGGCACCGCGCAGTGCGACGTGCTGTTCACCTTCCGGCCGCCGACCGATGACGGCATGTCCCTGGGTATCGAATTCAGCACGGACGTCTACGACCACACGACCGTGCTGTGCTGGGCGGAGCAGTTGGAGACGTTGCTGACCGCCGCGGCGGACGCCCCCGGCACCGAGGTGGCCCGGCTGCCTCTGCTGTCCGGATCCGCGCTGGACGCGCTGCTCACCCTGGGCGCGGGCCCCGTGCGGCCGCTGCCCGACGACCTCACGCTGACCGGGCTGTTGGCCCGCCAGGTGGCCCTGGCCCCGCAGCGCACCGCCCTGACCTGGCGGGAGGCCACCGGAACGGTCGCCACGCTCAGCTACGCGGGCTTCGACGAACGCTCCTCCCGCGTCGCCCACGCCCTGCGCGAGTACGGCGTCGGCGCCAACACGCCGGTCGCCCTCTGCCTGGCCCGTGGCGCCGACGTGCTCCCCGCCGTGTACGGAGTGCTCAAGGCGGGTGGCGGCTATGTGCCGATCGAACCGGACAACCCGCCCGAGCGGATCGCCGGGCTGGTCCGCGACAGCGGCGCCCGCGTCCTGCTCACCCAACGGCGGCAGACCGCCTCACTGCCGAAACTCCCGGGCGTGACCGTCCTCGTCGTCGATGACCACGAGGCGCTGAGCCGCTTCCCGGCCACGGTCCCCAAACCGGTGCCGCGCCCCCAGGACCTGGCGTACGTCATCTACACCTCGGGCTCCACCGGCCGCCCCAAGGGCGTGATGGTCGAACACCACAGCGTGGTCAACTATCTGACGACTCTTCAGGAAAAGTTCCGGCTCACCTCCGACGACCGGCTGCTGCTGAAGTCGCCGCTCTCCTTCGACGTGTCCGTGCGTGAGGTGTTCTGGGCGCTGAGCACGGGCGCCACCCTCGTTGTCGCGGAGGCCGGCCGGCATGCCGACCCGGACTACCTGGTCGAGGCGATCGAACGGGAGCGGGTGACGGTCGTCCACTTCGTGCCGAGCATGCTGCACGTCCTGCTGGAGACGCTCGACGGGCCCGGCCGCTGCCCCACCCTGCGCCAGGTCATGACCAGCGGTGAGACCCTGCCCGTGCAGACCGCACGACGCTGCCTGGAACTGCTCGGCGCGGAACTGCGCAACATGTACGGGCCCACCGAGACCACGGTCGAGATGACCGATTGCGAGGTCCGGGGCCGCACCGACACCGAGCGGCTGCCGATCGGCCGTCCCTTCCCGAACACCCGGGTGTACGTGCTCGACGACGAGCTGCGCCTCGTGCCCCGCGGGACGGTGGGCGAACTGTACGTCTCCGGGGCCCCGGTGGCCCGTGGCTACCTGGGCCGGCCGGCGCTGACCGCCGACCGCTTCCTGCCCGACCCCTACGGACCGCCCGGCAGCCGGATGTACCGCACAGGCGACTTGGGCCGGTTCACCGGAGAGGGCCTCCTGGACTTCCAGGGGCGCGGCGACTTCCAGGTCCAGCTGCGCGGCCACCGGATCGAACCGGGCGAGATCGAGACCGTGCTGTGCGAACAGCCGGGGGTGACCGCCGCCGTGGCCGTGGTCCGCAGGCCGGACAGCCCCGAGGCCGCTCACCTCGTCGCCTATGCCGTACGGGCCGAAGAGCCGCACGGCACGGACCAGGCCCTGCGCGCGAAGCTGGCCGAGCGGTTGCCGCACTACATGGTGCCGACGGCCGTCGTCACGATGGACGCCCTGCCGCTGACGGTCAACGGCAAACTGGACCGCGCGGCGCTGCCCGACCCCTGGGAGGCGCGAGCCACCGGAGATTCCGGCTCCGACGGCGCGGCGGTACCGGCACTGAACGGCCGCCGGGAGCTGGCGCTCGCGGAGATCTGGCGCAGCCTGCTCAGCACCGACGAGGTCGGCCCGCAGGACAACTTCTTCAGCCTGGGCGGCCACTCGCTGCTCGTGGCCACCCTGTCCGCCCGGGTCCGCGCGGAGCTGGGGGTCAGAGCGCCCCTGACCCTGTTCCTGCGCCACCCGGTGCTGCGCGACCTGGCCGCCGCACTTCCGGAGCCGGACGGCGGCCGGGCGCCGCGGGACGACGCCGGCCTGCGGCAGCGCGGTACCGACCGCGCTCCGCTGTCCGCGGCGCAGCGCCGGGTCTGGATCGACGAACAGCTGTGGCCCGGTACCGCCGCGTACACCGTCCCGGAGGCGTTTTGGCTGCACGGCCCGCTCGACGAGGCCGCCTTCGAGGGCGCCCTGCATGACCTGATGGCGCGGCACGAGGCCCTGCGCGTCAGGATCGTGGGCGGTGAGGACCCCTGGCTGGCGGTGGACGACCCGATGGCCGTACGGCTTTCGAGGGCCGACATGCGGGAAGACGGCGAGACGGCCGTGCAGCGGCTCCTGGAGCAGGCGGGGCGCAGGGTCTTCGCGCTGGACGGGCCTCTGGTGGAGGCGACCCTGGCGAGGACCGATGCCGAGGAGTGGGTGTTTCTCCTCACCGCGCACCACCTGGTCGTCGACGGCTGGTCCTTCGACATCCTGTGGCGGGATCTGGAGATCCTGTACCGCGATCGTGTCGCGGGCGGCGGCATCTCGCTTCCGCCGCCGCAGCTCACCTTCACCGACTGCACCTGGTGGGAGAGTGAACGTGTCGCCGCGGGCGGCAACCGGCCCCATCTGGCCTTCTGGCGGCAAGAGCTGGCGGGGATCGCCCACGGGGCCGGACCGGCGGACGCCACGGACACCGACCGTTCGGGCAGCAGCCGGGCAGTGCGGCTCGGGGGCGAGCTTTCCGACCAACTGCGCTTGATCGCAGCAGAGTTGGGTGTCACTCCGTTCGTCCTCACGCTCACGGCCTTCGCCCTCGCCGTGACCGCCGAGGGCTCCGCGGAACAGGTGATCGGCGTGGAGGTGGCGGGCCGAACCGATCAGCGGGTCGCGGACGTGGTGGGCCTCTTCATCAATCACGTCCCGCTGCGACTGCGCAGAAGGCCGGGGCTGACGGCACGACAGGCCGTCGCCGCCCTGGACGATGCCTGGCGCGGGGTGCTGGAGCATTCCGACGTGTCGTTCGACACGATCGTGGACGGTCTGGGCGAGCAGCGCGGCGCCGGCCGAGGTCCGGGCAGCGACATCGCCTTCTCCTACCTGGATGCCCGCACTCCGCCACGCCTCGACGGCATCCGCGTCACTCCGCTGGAGCCGGTGTTCAACGGGACGGCCAAGTTCGGCCTGCTGCTGGAGGTGTTCGACACCCCCGACGGACTGGTCGGTGTCTTCGAGCACCAGCTCGCGCGGTTCGGCCACGGCCGGATGACCCGTATCAGGAACCGGTGGGAAGCCCTGCTGCTCGGGCTTCTCGCCGACGTCGACGTCCCGCTGGACCCGCAGGGCTGA	MLERDPELVVALLGVLKAGGAFVPVDPTYPAARIRHMLDDSGARAVLLRQELRDRLPEDLRDGTGQVAVVPVGAESGAGTSTRRPVTPVEQEPRPERLAYIVYTSGSTGLPKGVMVEHRGIVSYLLGMLEHFPMGPRDRMLQVTSLSFDVSVYEIFLPLLTGGATVLPRSGSHTDAAYLSGLIAEHGVTSFHMVPSLLRTFVDGLDPRQCAGLRRIFVSGEALDTTLVVDVHDRLPCDVVNLYGATEVSVDSTWWTAPRDLPDAPVLVGRPMAGATAYVLDDEMRRLAPNEVGEVYLGGASVTRGYHGRAALTAQRFLPDPYGPPGSRLYRTGDLGRVEDNGELRLLGRIDHQVKLHGRRIEPGEIEAAMTAHPHVSLAAAVPAGAGAGATLTGFFTGAEADAEELRGFLAQRLPAALVPSRLVALDTLPLSPNGKIDRNALADIAARQDLAAVPPAPEHTDPVLRAVLDATADVLGGTPVAPHENFFDKGGNSLHATRLVAKLRSALDTAIGVRTVFEHQTPAQLADALRVTLDDAPDSGARGTAEGELSAAQHRMWLLAQISETPAEYAITLALHLAGALDTEALGWAVDAVVRRHDSLRSCFPDRDGTPVRAEVPAEALRLIHAPPEPGGDPDEVVRRVVAEETAGLDLVAGPLFRPVLVPLGAEEYLLVIVLHHIVADGWSTEVLLEDIAAHYRARTGGEAVPGRPVVSYRRYVDIERRNERDGVTDRDLEYFTTELHGIPEEVTLPLDRPRPAQRTGRGATLRPAFGPRGADAVRRLAAAHRTTPFVVLLAGLSTLVHRAGGHEDVVIGSAVAGRFDAELDDLVGLCLNSVALRWPVGPTTAFATVVERAERSLLDAMDHSAVPFARVVEKLGVRRDARRTPVFQVIALYDDFPDSPDLPGLSVRALETDDGTAQCDVLFTFRPPTDDGMSLGIEFSTDVYDHTTVLCWAEQLETLLTAAADAPGTEVARLPLLSGSALDALLTLGAGPVRPLPDDLTLTGLLARQVALAPQRTALTWREATGTVATLSYAGFDERSSRVAHALREYGVGANTPVALCLARGADVLPAVYGVLKAGGGYVPIEPDNPPERIAGLVRDSGARVLLTQRRQTASLPKLPGVTVLVVDDHEALSRFPATVPKPVPRPQDLAYVIYTSGSTGRPKGVMVEHHSVVNYLTTLQEKFRLTSDDRLLLKSPLSFDVSVREVFWALSTGATLVVAEAGRHADPDYLVEAIERERVTVVHFVPSMLHVLLETLDGPGRCPTLRQVMTSGETLPVQTARRCLELLGAELRNMYGPTETTVEMTDCEVRGRTDTERLPIGRPFPNTRVYVLDDELRLVPRGTVGELYVSGAPVARGYLGRPALTADRFLPDPYGPPGSRMYRTGDLGRFTGEGLLDFQGRGDFQVQLRGHRIEPGEIETVLCEQPGVTAAVAVVRRPDSPEAAHLVAYAVRAEEPHGTDQALRAKLAERLPHYMVPTAVVTMDALPLTVNGKLDRAALPDPWEARATGDSGSDGAAVPALNGRRELALAEIWRSLLSTDEVGPQDNFFSLGGHSLLVATLSARVRAELGVRAPLTLFLRHPVLRDLAAALPEPDGGRAPRDDAGLRQRGTDRAPLSAAQRRVWIDEQLWPGTAAYTVPEAFWLHGPLDEAAFEGALHDLMARHEALRVRIVGGEDPWLAVDDPMAVRLSRADMREDGETAVQRLLEQAGRRVFALDGPLVEATLARTDAEEWVFLLTAHHLVVDGWSFDILWRDLEILYRDRVAGGGISLPPPQLTFTDCTWWESERVAAGGNRPHLAFWRQELAGIAHGAGPADATDTDRSGSSRAVRLGGELSDQLRLIAAELGVTPFVLTLTAFALAVTAEGSAEQVIGVEVAGRTDQRVADVVGLFINHVPLRLRRRPGLTARQAVAALDDAWRGVLEHSDVSFDTIVDGLGEQRGAGRGPGSDIAFSYLDARTPPRLDGIRVTPLEPVFNGTAKFGLLLEVFDTPDGLVGVFEHQLARFGHGRMTRIRNRWEALLLGLLADVDVPLDPQG	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	366.73	gnl|BL_ORD_ID|4935|hsp_num:0	5928			579	1629	colistin A; colistin B
BGC0000458.1|Viomycin_2 # 6876 # 8021 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=14bp;gc_cont=0.723	BGC0000458.1|Viomycin_2 	6876	8021	+	Loose	1300	29.261	mdtO	39.13	3003549	protein homolog model	n/a	n/a	nucleoside antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCCACCCACTTCGCCGCCATCGACAGCGGCGGCCACACCCGGCGACACCACCTGCCCCCCGCCCATGTCCGGCAACCCCGTGCTGGAGCACGTCAGCCGGGCCATGGCCGCCTATCCGGTCACCCCGGTCCGCACGGTCCGGACCGAGATCGCCGGCATCCCCCGGACCATCACCCTGAAGCTGGAGGGCCACTCGCCCTGGCGATCGGTCAAGGGCCGCACCGCACTCAGTCTGATCCGGTCGGTGGCCGGTGACCTGACCGCCCCCGATGCCACCGTCGTCGAATCGACCTCGGGCAATCTCGGGCTGGCGCTCTCCGCCATCTGCCGGGACCTGGGGCTGCGTTTCATCGCCGTCGTCGACCACCGGCAGTCCCCCGTCATCCAGCAGGCCATCGAGGCCAACGGCGGGGAACTGGACTGGGTCAGGACCCCCGACGACGCCACGACCCACCTGCAGGACCGGCTGGCCCGGGTGCGCGAGCTGGAGCGGGACCTGCCGCACGCCGTATGGCCCAACCAGTACGAGAACGACGCCAACTGGCGCATCCACGAAACCTGGACCGCGCCCGAGTTCGACGCGCAGGTGACGCACCGCGCACAGGCCCTGTTCGCCGGGGTCTCCACCGGGGGCACCCTCGCCGGCCTGTCCCGCCATTTCCGGCGCACCCGCCCCGGGCTGCGGATCGTCGCGGTGGACGTCAGGGGCTCGACCGTGTTCGGCGGGGTGCCCCGCCCCCGCACCCTGACCGGAATCGGCGCCGGCAGGAGGTCCGCGTTCCTCACCCGGGCAAGCACCGACGACGTGCTCCTGGTCGACGAACGGCAGGCTGTGGCCTGCTGCCACACCCTGCGGGCGGACACCGGCACAGCGGTCGGCGGTTCCAGCGGTGCGGTACTGGCCGGCTGTCTGGAGTACCTCTACCGGCATCCCGAGGTGCGTCACGCGCTGTGCCTCTGCCCGGATCTCGGCGACCACTACGGCCCGACCGTCTATCACCCGGCCTGGCTGGACCGGATGGGCCTGCCCTCCGAGGCGCACCGGCTGCGCCACCGAACGGGAGCGGCCTGCCCCGGCTTCGAACCGGTCGACGACATCACCCCAGCCCCCAGCGCCCCGTCCGAGGAGGACGCATCGCGATGA	MPPTSPPSTAAATPGDTTCPPPMSGNPVLEHVSRAMAAYPVTPVRTVRTEIAGIPRTITLKLEGHSPWRSVKGRTALSLIRSVAGDLTAPDATVVESTSGNLGLALSAICRDLGLRFIAVVDHRQSPVIQQAIEANGGELDWVRTPDDATTHLQDRLARVRELERDLPHAVWPNQYENDANWRIHETWTAPEFDAQVTHRAQALFAGVSTGGTLAGLSRHFRRTRPGLRIVAVDVRGSTVFGGVPRPRTLTGIGAGRRSAFLTRASTDDVLLVDERQAVACCHTLRADTGTAVGGSSGAVLAGCLEYLYRHPEVRHALCLCPDLGDHYGPTVYHPAWLDRMGLPSEAHRLRHRTGAACPGFEPVDDITPAPSAPSEEDASR	MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTVQLWVGCLLVILISMTFEIPFVALSLAVLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLMRTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPSRAISQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQNAWWQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAVAEGQCWQSDWRISESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMAADAFTNPDYMRYAVKTLLACLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVMPWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIRDRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGTLGMLSKVMRIPRQQEVTALRTYLQIRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDLLHAWDATWNSAQALDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLFARLPDWTAPALTPATEQAQGATQ	55.78	gnl|BL_ORD_ID|1893|hsp_num:0	2056			582	720	acriflavine; puromycin
BGC0000458.1|Viomycin_4 # 9091 # 10260 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=5bp;gc_cont=0.724	BGC0000458.1|Viomycin_4 	9091	10260	+	Loose	475	28.4906	PST-2	28.24	3006977	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	PST beta-lactamase	ATGACCGGCCCACTCGGCGCGGGCCCGCAGGCGCTGCCGGCGGCGCCCCTGGAGGACTGGCTGCGTGAACGCTACTTCCAGGCGAAGACCGACATCAGCAGCAGCGGCGTGCACAACTACACCTTCGGGGAACTCCGCGCCCTCGACCCCGCGCTGCTCGGTACGCGGGAGCTTGACCAGCTGATGTTCCGTGACGGTCCATCGCTGGGTGACGAGCGGCTGCGCGCCGCCGTGGCGGCCCGGGTACGCCCCGGCCCCGGCCATGTGGTGATGACGACCCACGGCTCCAGTGAGGCGCTGTACCTCGCCTTTGCCGCACTGGTGCGCCCCGGGGACGAGGTCGTGGTCGCCACGCCCGCCTACCACTCGCTGTCGGGGCTCGCCACCGCGGCCGGCGCGAGCCTGCGTCCGTGGCCGCTGCGGCCGGAGAACGGCTTCGCCCCGGACCTGGACGATCTGCGGGCGGTGCTCAGCGACCGCACGCGCCTGGTGGTGGTGAACTTCCCGCACAACCCGAGCGGTGCCTGCGTGGACCCCCGAGGCCGTACGGAGCTGCTCGATCTGGTCGCGAACAGTCAGGCCGTTCTGCTGTGGGACGGCGCCTTCACCGATCTCGTCCACGACCACCCGCCGCTGGCCGAACCGTCGCAGGACCTGGACCGCGTGCTGAGCTTCGGCACGCTGTCGAAGGCCTACGGCCTGCCGGGGCTGCGGGTCGGCTGGTGTGTGGTCCCGCAGGACCTGGTTTCCGAGCTGGTGCGGATCCGGGACTATCTGACGCTCAGCCTCTCTCCGCTGGTGGAACGAGTCGCAGCCGTCGCCGTGGAGCACGCCGACGCCCTGATCACTCCCCGGCTGACCGAGGCGCGCCACAACCGGCGACGGGTACTGGAGTGGGCGGCGGCGAGCGAGGGAGCCATCGACTGCCCCGTTCCACGCGGCGGGGTCACGGCCTTCCCCCGGTTCACCGCCCACACGGACGTCACCGACCTGTGCGAGCGGCTGCTGGCCCGGCACGGCGTACTGGTGGTCCCCGGCCGGGTCTTCGGGCAGGCCGACCGGATGCGCATCGGATTCTCCTGCCCGCGCCCGGAGCTGGAACGCGGTCTGGCCGCGATCAGCGAGGAGCTCGGTACGCACGCGCGCGGCCGGCGAAGGGGGACGGGATGA	MTGPLGAGPQALPAAPLEDWLRERYFQAKTDISSSGVHNYTFGELRALDPALLGTRELDQLMFRDGPSLGDERLRAAVAARVRPGPGHVVMTTHGSSEALYLAFAALVRPGDEVVVATPAYHSLSGLATAAGASLRPWPLRPENGFAPDLDDLRAVLSDRTRLVVVNFPHNPSGACVDPRGRTELLDLVANSQAVLLWDGAFTDLVHDHPPLAEPSQDLDRVLSFGTLSKAYGLPGLRVGWCVVPQDLVSELVRIRDYLTLSLSPLVERVAAVAVEHADALITPRLTEARHNRRRVLEWAAASEGAIDCPVPRGGVTAFPRFTAHTDVTDLCERLLARHGVLVVPGRVFGQADRMRIGFSCPRPELERGLAAISEELGTHARGRRRGTG	MKLLFAALFVVMFCGLARAGDSLPELRIEKIAEGVYLHTSFQQVQGYGLVDANGLVVLDGQGAYIIDTPWSERDTAALVAWLQERNYQVKASVSTHFHDDRTAGIEYLNAISVPTYASARTNALLKQNGKALATETFDDAPLWLLEGKVEVFYPGAGHSVDNLVVWLPEQKLLNGGCFVRAAAAGTLGNTADAVVSEWAASAERLQRRYPDAQLVIPGHGVPGDVSLLEHTRKLAVAATAKD	160.74	gnl|BL_ORD_ID|4564|hsp_num:0	5634			225	480	
BGC0000458.1|Viomycin_5 # 10257 # 11600 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=6bp;gc_cont=0.713	BGC0000458.1|Viomycin_5 	10257	11600	+	Loose	700	64.3142	tap	28.69	3000343	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACCTCGACGCCGTGCGGCGGAACAGCCGAGCAGAAGTCCGCGTCCGCCGGCGAAGCCGCCGAGGAGAAGCCCGCGTCGCTGCGGCGCAACCGTGACTTCCGGTTCTGGTGGGGCGGCACCATGCTCAGCGCCATCGGCGACGAGCTCACCGCCGTCGCCCTGCCGCTGATCGTGCTGCTGATCACCGACTCGCCGCTGCACGCCGGCCTCGTCGGCAGCGTGGAGTCGATCCCTCCGCTGCTCCTGAGCCTGCCGCTGGGCATGCTGGTGGACCGCGTCTCGCGGCGGGCGGTGATGCTCGCGGCCTCCCTGCTCAGCGCGGCCTCGATCGCCACCGTGGCCATCGCCTTCCTGTTGGACGGGCTGAGCCTGCCCCAGTTGTACGTGGTCGCGTTCGTCAACAGCCTCGCGGCGACGGCGTACCGCATCGCGGACACGGCGGCACTGCCGGGAATCACCGGCCCGCACAAGCTGGGCGAGGCCGCGAGCCAGAGCGAGACGATCTTCGGTACCTCGGCTCTGATCGCGCCGCCGCTGGCGGGCCTGATGTTCGAGACCATGAGCCCCGCCGCACCGTTCCTCCTGGACGCGCTGTCCTTCGTGGCCGTCGCCGCGGCCATCCTGGCGATCCGGTCGCGGCTCGGACCCGAGGGCGCCCCGGAGCCACTGCGCTGGCGCCGCGAACTGACCGCCGGCATGCGGATCACCGCACGGCTGCCGCTGGTGCGCGCCCTGACGCTGCTGACGACCCTGGGCGACTTCCTCTTCGCGGGGATCGGGCTGCTGCTCATCGTGCTGGCCAAAGGGAGCGGCGCCTCCGGCTTCGAGGTGGGCGCCGTCTTCACGGCCGCCGGTGTGGGCAGCCTGCTCGGCGCGGCCCTCGCTCCGCGCATCGAGGCGGGTCTCGGGCTGCGGACCGCCGTCGTCGGCAAGCACTGGCTGACCGCGCTGCTCTTCCCCCTGCTGCTGGTCGACCTGCCCGGATGGGGGATCGGGCTGGTGTGGGGACTGGTCGCGCTCCAGGTCGCCGTACTGAACGTGATCCAGATGAAGTATCTGATGAGCCAGGTCCACAGCGACCAGCTCGGCAGGGTGCAGGGCTTCATGACCTTCCTGTCGAAGAGCAGCCTCCCCCTCGGCTACGCCCTGACCGGTCTCCTCCTCGACCGGTGGGGGACCCGGGGCACCATCGTGTTCTTCGAAGTCGTGCTGCTGTGCCTCGCCGTGTACGCCCTCCTGGGACGCGGTCTGCGCGCCTCCCACGTGACCAGGAGCGAAGACGCCGGGAGCGGCGCGCCTGACGACCAGCCACTGCCGAGCCGACGGGGAAGCGAGCGATGA	MTSTPCGGTAEQKSASAGEAAEEKPASLRRNRDFRFWWGGTMLSAIGDELTAVALPLIVLLITDSPLHAGLVGSVESIPPLLLSLPLGMLVDRVSRRAVMLAASLLSAASIATVAIAFLLDGLSLPQLYVVAFVNSLAATAYRIADTAALPGITGPHKLGEAASQSETIFGTSALIAPPLAGLMFETMSPAAPFLLDALSFVAVAAAILAIRSRLGPEGAPEPLRWRRELTAGMRITARLPLVRALTLLTTLGDFLFAGIGLLLIVLAKGSGASGFEVGAVFTAAGVGSLLGAALAPRIEAGLGLRTAVVGKHWLTALLFPLLLVDLPGWGIGLVWGLVALQVAVLNVIQMKYLMSQVHSDQLGRVQGFMTFLSKSSLPLGYALTGLLLDRWGTRGTIVFFEVVLLCLAVYALLGRGLRASHVTRSEDAGSGAPDDQPLPSRRGSER	MTNTKRGPLLLILFAALTAGAGNGITIVAFPWLVLQHNGSALDASIVAMAGTLPLLVATLIAGAAVDYLGRRRVSMISDLLSALSVAAVPVLALIFGVDAVNVAVLAVLAGLGAFFDPAGMTARETMLPEAAGRAGWTLDHANSVYEAVFNLGYIVGPGIGGLMIATLGGINTMWVTAGAFCCSILAISVLRLEGAGAPDRSVLTEAVLAGIVEGLRFVWYTPVLRTLAIVDLVATGLYMPMESVLFPKYFTDRNEPTELGWVLMALSIGGLLGALGYAVMSRYMSRRATMLTAVITLGVAMTVIAFLPPLPLILVLCAIVGFVYGPIAPIYNYVMQTTAPQHLRGRVVGVMGSLAYAAGPLGLILAGPLADAAGLHATFLALSLPMLLLGVVAVFLPRLRELDLASKP	109.29	gnl|BL_ORD_ID|1577|hsp_num:0	1720			63	1137	tetracycline
BGC0000458.1|Viomycin_6 # 11597 # 14818 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=9bp;gc_cont=0.746	BGC0000458.1|Viomycin_6 	11597	14818	+	Loose	1000	186.422	almE	29.5	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGACGGATCTGGACTTCACCAGCTGGGATCTGCGCACCGAGGCCGACCGGCGGGCGTTCCCCGGCGGACTGGACGGTCCCGCCCCCTCCTGGAACACGGACACGACCCTGGTCAGGATCGTGTGGGAGCAGGTGACACGCACACCGCACGCCGAGGCCGTACGCGTGGGTGACCGGGCCCTGACCTACCGCGAGTTGGCCGACTCCGCGGCCAGGGTGGCCCGTTGGGCGGCGGGGCTGCGGAGCGACCGGGAACGGGAGCTGCGCATCGGCGTGGTGGCACACCGGTCGCTGCCCGTCTACCCGGTGCTGCTCGGGGTGCTGGCCGCGGGCGGGTCCTATGTGCCGCTGGACCCGGCGGCACCGGTGCGGCGGCTGCGTGAGGTCGCCCGGCGGGCGGAGCTCGCAGCGGTGGTCACCGACGCGGAGGGGTGGGCCGGGCTCGGCCTCTCCGACATCGCCGGGCTCCTCGTCGACCGTGCGCTGCCGTTCCAGCGCGGCAGGCTCGGCGGCGGGACGCTCACGGAGTTCGAATCGCTGCCCGAGGCCGACGGCGCGCTGCCCGGGGCCGGGCGCCCGGGCGGACCGCGGCCGGACGACGTGGCGTACACGGTCTTCACCTCGGGTTCCACCGGCGCGCCCAAGGGTGTGCTCGTCGAGCATCGCGGCGCCGTCAACCTGGCACGGTGGGTGGCCGGCACCACGGACCTCGGGCCGGGAAGCCGGGTCACCCAGAACGCCTCCCTGCACTTCGACGCCTCCGTCCAGCAGATCTTCTCCGCCTGGTCGGCCGGAGCGACCCTGCTGCCCGTACCCGAGACCGTGCGGGTCGACGGCGCGCGGCTGTACGGCTGGCTCGCCGAACAGGGCGTGACCCACTGGGATTCCGTGCCCTCCCTGTGGGCCCCGGTCGTGGAACACTGCGCCGGGCGCATCGCCGCGGGCGAGACGGTCCTGCCCGCCCTCAGGGCCGTACTGCTGGCGGGCGAGGTCCTGCCGGCCGCACGGGTCAACGAGTGGCGGCCCTGGCAGCAGGGGCATCGGCTGTTCAACATCTACGGGCCCACCGAGGTGACCGTCGACGCCACCGCGTACGAGGTGACAGGCCCCGTCACCGGCGGTGCCCCTCCCATCGGCCGTCCCCTGCCGGGGCTGCGGGCCCTGGTCCTCGACGCGGACGGGCACCCGTGCCCGCCGGAGGCCGACGGCGAACTCCTCCTCGGTGGCATCGGCGTCGCCCGGGGCTACCTCGACGATCCGGCACTGACCCGCGAACGGTTCGTCGCCCGCGAGGGAGCTCGCTGGTACCGCACCGGAGACCTCGTCCGGTACACCGCGGAAGGGGACCTGGTGTTCTCCGGGCGTCGCGACGACCAGGTGAAGGTGCACGGCGTGCGCATCGAACTGGCCGAGGTGGAACGGGCGTTGCACGCAGACCCGCGGGTCGCCGAGGCGATCGCCGTGGTGCTGGACGACGCACAGGGCCGCCATGAACTGGCCGCAGCCGTCACCACCCGGACGCCGGTCGCCGGTGCCGCCCTGCGTGCCTCGCTCGCCGAGGAGCTGCCCGCCGCCATGGTCCCCACGCGGGTGCTCGTCGTCGACGCCCTGCCGCGCACCGCCAACGGCAAGGCCGACCGGAGGGCGGGCGCGCGCATGGTGCGGGACTTCGCCGACCCGGGCGACGGTGGTACCCGGCCCGCGGCCCTGACCGCCACCGGGCGGCGGCTCCTGACGATCTGGCGCCAGGTGCTGGGCCTGCCGCAGCTCGGTCCGGACGACGATTTCTTCCGCAGCGGCGGGGACTCCATCGCCACCCTCCGGGTGCGTCACGAGTGCGCCGGGGCCGGGCTGCCCATCCAGTCGGTGGACATGTTCGCGCACCCCACGGTGCGACGACTCGCCCGCCATCTGGACCGCACTCCGGCCGAGCGGCCCGCGACCGCCCGGAGCGTTCCCGGCATCGGCGCGTCGACGCTGCTGCCCGCGCAGCGGCGGCTCGCCGTGGCGACGCTCCTGAGCGACCGCGTACCGCAGTTGGGACTGGTCCAGGAGAGCCACGAGTACGAGGAGGAACTGGACGCCGACGCGCTGCGCACCGCGCTCGATCTGCTGGCCGAGCGGCACGAGGTGCTGCGCACGGGGGTGGAGAGTCGCACCGACGGCTTCCGCGCCAGGACCGAGGAGCGGGTGACGGTTCCGCTCACCGTGCACCGGTCGGACGGCAGCGGCGCGGCCGCACGGCGCGAACTCGCGCGTTCCCACGCCGACGCCGTGCTGCGGGAGGGGTTCGACCTGTCCGCGCCGCCGCTGCTGAAGGTCGCCGCCTTCGAGCTGGAACGGGGCCGGTTCACCCTCGTGTGGACGCTTCACCACGTCATCTCGGACGGCTGGTCCTGGGAGCTGCTCCAGCACGAGTTCGAGATGCTGTACTCGGGCCTCCGCCAAGGCCGCTTCCGCCCGCTGCCCGCGCCGGCGCTCCCCCTGCGCGAACTGGTCCACCGGCTGGCGGAGTCGCCCTCCCCGGCGCCCTCGCCGGAGTGGCTCACGGAACTGCGCGCCGTCGGCCCCCTGCCCCTGCCGCCGGGCCGCGTCGGCGGGGACACGGACCGCGCGCACGTCGACTGGGCCGTCACGAGGGAGACCGACGCGGCGCTGCGGGCCGTGGCCACGGCCGCCGGGTGTGCGCCCAGTACCGGATATCTCCTCGCCTACGCCGAGGCTCTGGGCCGGGTGTGCCGCCAGCGTGCCTTCCCGCTCGGCATCGTCTCCTCCGGCCGCAACGCCGACATCCCGCACATCGAACGTGCCGTGGCCTGTCTCGCCCGCAGTCTGCCGGTGCCGGTCGACCTCTCGGGCACCACCGGCGAACGCCTCCGACGTCTGCACGGTCACCTGGCCGCAGTCCTGGCCCAGGACTGCGCCGACCCCGACGAACTGCTGGCCGGACTGGCGCCGGCGGTACGCGATCCCGCCGCCGCCTTCGTGTTCCAGAACTACCCCGACGCACCGGCCGAGCCGGTGCCCCTGCGTCGCGTTCCCGCCGCCTCCTGGTGGCGCGAGACCGGGTCCGAACCGCTCGCTCTCGTCTGCCACGAGGGGGGCGTCGAGGGCTTCCACTGCCGTCTCGAGTACGACCCCGCCGAGGTCTCCGCCGCCTGGGCGGCTGTGCTCGCCCGTGAGATCCGCAGGGCCCAGGACCGCCTGGCCGCAACGGAGTAG	MTDLDFTSWDLRTEADRRAFPGGLDGPAPSWNTDTTLVRIVWEQVTRTPHAEAVRVGDRALTYRELADSAARVARWAAGLRSDRERELRIGVVAHRSLPVYPVLLGVLAAGGSYVPLDPAAPVRRLREVARRAELAAVVTDAEGWAGLGLSDIAGLLVDRALPFQRGRLGGGTLTEFESLPEADGALPGAGRPGGPRPDDVAYTVFTSGSTGAPKGVLVEHRGAVNLARWVAGTTDLGPGSRVTQNASLHFDASVQQIFSAWSAGATLLPVPETVRVDGARLYGWLAEQGVTHWDSVPSLWAPVVEHCAGRIAAGETVLPALRAVLLAGEVLPAARVNEWRPWQQGHRLFNIYGPTEVTVDATAYEVTGPVTGGAPPIGRPLPGLRALVLDADGHPCPPEADGELLLGGIGVARGYLDDPALTRERFVAREGARWYRTGDLVRYTAEGDLVFSGRRDDQVKVHGVRIELAEVERALHADPRVAEAIAVVLDDAQGRHELAAAVTTRTPVAGAALRASLAEELPAAMVPTRVLVVDALPRTANGKADRRAGARMVRDFADPGDGGTRPAALTATGRRLLTIWRQVLGLPQLGPDDDFFRSGGDSIATLRVRHECAGAGLPIQSVDMFAHPTVRRLARHLDRTPAERPATARSVPGIGASTLLPAQRRLAVATLLSDRVPQLGLVQESHEYEEELDADALRTALDLLAERHEVLRTGVESRTDGFRARTEERVTVPLTVHRSDGSGAAARRELARSHADAVLREGFDLSAPPLLKVAAFELERGRFTLVWTLHHVISDGWSWELLQHEFEMLYSGLRQGRFRPLPAPALPLRELVHRLAESPSPAPSPEWLTELRAVGPLPLPPGRVGGDTDRAHVDWAVTRETDAALRAVATAAGCAPSTGYLLAYAEALGRVCRQRAFPLGIVSSGRNADIPHIERAVACLARSLPVPVDLSGTTGERLRRLHGHLAAVLAQDCADPDELLAGLAPAVRDPAAAFVFQNYPDAPAEPVPLRRVPAASWWRETGSEPLALVCHEGGVEGFHCRLEYDPAEVSAAWAAVLAREIRRAQDRLAATE	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	192.99	gnl|BL_ORD_ID|4935|hsp_num:0	5928			132	1626	colistin A; colistin B
BGC0000458.1|Viomycin_7 # 14908 # 18174 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.743	BGC0000458.1|Viomycin_7 	14908	18174	+	Loose	1000	126.331	almE	27.56	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGACCACCACGTCCCACGCAGCGACCGACCCCGCCCTCGCTCTGGACACACTGCTGACCCCCGAGGAGCGGGCGGCCTGGAGGGCTCTCAACGACCAGGCCCGATCGTGGCCCGAGGGCCTCGCCCTGGCGCATCGGCTCGAAGAGGCGGCCGCGCGGCGCGCCGACGAGCCCGCCGTGCAGGCCGACGACGGCACCTACACCTACCGGGAACTCCACGCCGAGGCCGACCGGATCGCCGCGCTGCTGGCGGAACAGGGCGTGACGGAGGGCAGTACGGTGGCCGTCGCCACGGCCCGCAGGCTGGGCGAGTACGCCGCCCTGCTGGCCGCGCTCAAGCTGAACTGCGCCTACCTGCCACTCGCGGCGGACGGCCCGGCGCGTCGGCTGGAGTTCATGCTGGCGGACTCGGCGGCCGCGGCCCTGGTGGCGGACGCCCCCGCGGCGGCCCTGCTCTCGGAGGCGGGGGTCGGCAGCAGTCTCACGGCACGGGTGGTGGCGGGGGCGAGCCGTGCCGCCCCCGCCGGCTGGACCACCGGTGAACCCGCCCCGCGCGGCCGTCGGCCCTCGGCCGAGCCGTGGGACCGGACCGCGTACGTCGTCTACACCTCGGGCAGCACCGGCACCCCGAAGGGCGTGATGACCGGCGAGGAGGCCCTGCTGAACTTCTGCGCGTGGTATATCGACCGCCACGACGTGCTCCCCCACGACCGGCTGTGCCAGACCGCGCCGCTGACCTTCGACCCCTCCGTGCAGCAACTGTTCCCCGCATGGCTGACGGGCGCGTGCCTGGTGGTCGTGCCCGACGAAGTGCAGCGCGACGGAGGGGAGTTCCTGGACTGGCTGGCCGCCGAGCGGATCACCCACCTGGACATCGTGACCCCGCACTGGGTGCAGTTGCTCGACGTGGCCGCGCGGCGCGGCCGGGCGGCGCTCCCCGCGCTGCGCTGGATCGTCGTCGGCGGGGAGACGTACTTCTTCCACCAGACCCACCGCTGGCACCGCGTCGTGGACTCTCCGGCCCGCCTCAACACCATCTACGGGCCCACCGAGGCGACCGTCAACGCCACCGAGTTCCTCGTCGACCCGGGTGTGACGGAAGGCCAGGTCCCCATCGGCCGGCCGCTGCCCAACTACCGTGCGTACGTCCTCGACGAGACGGGGGCGCTGTGCCCGCCGAACATCACGGGTGAGCTGTACCTGGCGGGCACGGGGCTGGCCCAGCGGTACTGCTCCCTCGAAGCGACCGAGCGAAGCTTCCACGAACGGACGGTGGCCGAGGACAGCACCGAGAGGCTGTACCGGACGGGCGACCTGGCCCGGCTCGTCGAGTTCGACGGGCAGTGGGCGCTGGAGTTCCAGGGACGTACCGACACGCAGGTGAAGGTGTCCGGCTACCGCATCGAACTGGAGGAGGTCCAGGCGGCGTTGGCCGCCGTCCCGGGTGTCACCGCGGCTGCCGTCGTCCTGCGCACCGAGCCGGCCAAGCAGATCGTGTGCGGCTACGTCGCCCCCGGCCTGACCGGGGAACAGGTCCGTGCCGAGCTGGCGGAGCGCCTCCCGGAGTACATGCTGCCGCACGTGATCGCGCCCCTGCCGGCCCTGCCGCTGACCGCCAACGGCAAGGTCGACAAGGACCGGCTGCTCGCCCTGGCCGCCGAGCGGCATGCCGGCGCGGCGACAGGCGGCGAGGAGCCGCGCGGGCCAGTGGAATCGGCGATCGCCGCCATCTGGGCGGAGGTACTGGGGGTGCCCCGGGTCGGTGCCGACGACGACTTCTTCGTCCGCGGAGGGTCCTCGCTGCTCGCCTTCCGGGTGGTCGCGCTGCTGCGTGAGAAGGGGGTGGCCATCCGCGCCGCAGACCTCCTGCAGGCCCGCACGGTGCGGGCCCTCGCCGAGCGGGCCACCACCGACGGGCAGCTCGCCGCAGCCGACGGGACCGACGCACCGGACGACGGCGCGGATGACATTGCGCTGCTGCCGGACCCCCGGCACGAGCTGGCGGACGACACGGGACAGCACCTCGACCTGCCCCCGGCCACCTCACTCGCTCTGCTCACAGGGGACACCGAGGACGTCGGCGACCACGCGGTCCTCACCCTCGGGCTGCCCCTGGACATCGATCCCGATGCTGTGCGCGAAGCACTCACCGAGGTCGTCCGACGCCACCCGCTGCTGCGGACGAGGCTCGACACGAGCCAGGCGCGGCTGCGGCTGCGGGCCCTGCACGTCGTCCGCTTCGACCTGCCGGTCCTGGAGGGGAACAGCCCGTCCCTGGTCGACCGGGTGCGTCCGCTCCTCTTCGGCCACACCGGGCTGCGCCGCCAACTGCCCGTTGCCGCCGCCCTGGTGAGGCTGCCGGGCGGAACGCGGCTGCTGCTGGCGGTGCGGCATCTGCTGGTGGACGGCAACGCCCTGCGCCGTATCTCCCGTGAACTCGCCGCCGAACTGGGCCTGGGGGCGCGGCCCACCCCGTCGGCGCCGCTCACCGAGCAGTTGGCGGAGCTGCGCGAGCGAGCCCGCGGCATGCGCCCCGTACGGCATCTCAACGCCTACCTGGAGGCGGAACGGCAGGCCCAGCGACGGCTGGCCCCCCGCCTCACCGCCGAACACACGGTGACCGAGATGGCGGCCGGCGAGCTGCCGGCGTCCTTCCTCGACGGCACCCGGGGCGCGCTGGAGCCGCGGCTGCTCGCGGCGGCAGCGCTCGCCGTGCGCCGGTGGCTGGGCCTGACGGCCGTACCGCTGAGCCTGCCGCGGCAGGGCTCCCCCGCGGAGACCGTGGCCAACCTCTCCGACGTGGTCCCGCTGTTGATCACCGCGGACGGCGACGGTGACGGCGAGGCGGGACGGGCGCTCGGCGCGGCCACCGCCGCGTGGGCCGAGCACGCACGGCCCGAGGCCCACTGGTCGGCGGCACTGCTGATGCACTGCCCCGGGCTCGCGCACCGCTGGCCCGGCCGGCGGGAGGTGCTCACCAGCTCGTTCCTGGTCGCGGTGGAGCTCGCGGAGGCGACCACCGCCGGCCTCGGCACCGCGGTACCGGGCACGGGAGGGCGGATGACCGACCACGACAGTCCCACCGCCGCCGACCCGGCGCGCTCGGGATCCGTCCAGTTCACGGTCGCGGCCGGTTCCGCGGGCCCTTCGCTGCGGCTCATCGGCTGGGACCTTCCCGCGGCGGTCCTCGAAGAGCTCGCCCCGCTGTGGCGTGCCGCGCTGGCCGATGTCGCGGATCTCCGGGTGAGCGGAGGAGAAGCAGTATGA	MTTTSHAATDPALALDTLLTPEERAAWRALNDQARSWPEGLALAHRLEEAAARRADEPAVQADDGTYTYRELHAEADRIAALLAEQGVTEGSTVAVATARRLGEYAALLAALKLNCAYLPLAADGPARRLEFMLADSAAAALVADAPAAALLSEAGVGSSLTARVVAGASRAAPAGWTTGEPAPRGRRPSAEPWDRTAYVVYTSGSTGTPKGVMTGEEALLNFCAWYIDRHDVLPHDRLCQTAPLTFDPSVQQLFPAWLTGACLVVVPDEVQRDGGEFLDWLAAERITHLDIVTPHWVQLLDVAARRGRAALPALRWIVVGGETYFFHQTHRWHRVVDSPARLNTIYGPTEATVNATEFLVDPGVTEGQVPIGRPLPNYRAYVLDETGALCPPNITGELYLAGTGLAQRYCSLEATERSFHERTVAEDSTERLYRTGDLARLVEFDGQWALEFQGRTDTQVKVSGYRIELEEVQAALAAVPGVTAAAVVLRTEPAKQIVCGYVAPGLTGEQVRAELAERLPEYMLPHVIAPLPALPLTANGKVDKDRLLALAAERHAGAATGGEEPRGPVESAIAAIWAEVLGVPRVGADDDFFVRGGSSLLAFRVVALLREKGVAIRAADLLQARTVRALAERATTDGQLAAADGTDAPDDGADDIALLPDPRHELADDTGQHLDLPPATSLALLTGDTEDVGDHAVLTLGLPLDIDPDAVREALTEVVRRHPLLRTRLDTSQARLRLRALHVVRFDLPVLEGNSPSLVDRVRPLLFGHTGLRRQLPVAAALVRLPGGTRLLLAVRHLLVDGNALRRISRELAAELGLGARPTPSAPLTEQLAELRERARGMRPVRHLNAYLEAERQAQRRLAPRLTAEHTVTEMAAGELPASFLDGTRGALEPRLLAAAALAVRRWLGLTAVPLSLPRQGSPAETVANLSDVVPLLITADGDGDGEAGRALGAATAAWAEHARPEAHWSAALLMHCPGLAHRWPGRREVLTSSFLVAVELAEATTAGLGTAVPGTGGRMTDHDSPTAADPARSGSVQFTVAAGSAGPSLRLIGWDLPAAVLEELAPLWRAALADVADLRVSGGEAV	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	195.68	gnl|BL_ORD_ID|4935|hsp_num:0	5928			138	1617	colistin A; colistin B
BGC0000458.1|Viomycin_8 # 18171 # 18959 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=15bp;gc_cont=0.739	BGC0000458.1|Viomycin_8 	18171	18959	+	Loose	750	26.1794	mdtH	31.82	3001216	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGTGAGCTGACCGACACCCGGTGGCTGCGTCCGTGCGCGGGGCACTGGCGAGAGGGGACCGGGCCCGTGCTGCTGTGCCTGCCCCACGCCGGCGGTGGCGCTCTGAGCTATGCGGGATGGGACCGCCACCCGCTGGGCGGCTTCGAACCCGTGGCCGTGTGCCTTCCCGGCCGCGAGGACCGCTTCGCGGAGGATCCCGTCTCCGGCTGGGCGGCGTTGGTGTCCGCGATCGCCGACTCCCTCACGCCCCTGGCGCACCGCCCGTTGGCGGTGTTCGGCCACAGCATGGGTGCGCTGACCGGCTACGAACTGCTGCGCGAGCTGGCGCGGCGCAAGCGGCCGGCCCCCCTGCTTCTGGCCGTCTCCGCGCACCGGGCGCCGCAGGAGATGCCGACCGCGGCCGGACCGCCCCGCTCCCCGCGGGAGCTGCTCGACTACGTACGACGCCTCGACGACGGCGGCACGGCCGAGCTGCTCGACGACCCGGAGTGGCGCGATCTGGTGCTGCGGCCGCTCGGCGCCGACCTCCGGCTGCACGACACCTACCGGTCGTCCGCCGAACCCCCGGGACAGCCCCCGCTGGCCACGCCCTTCGTCGTGCTCACGGGCGAGGACGACCCCACCGTCTCCGACCGCACCTACGCGGGCTGGGCTGCGCTTACCCACGCGGTCAGCGCCCGAAGGGTCTATCCGGGCGGCCACTTCTACCTCAGGGAGCAGCGGGACCGGCTCCTCACGGAGCTGGGCCGGGACCTGGAGAACGCGATGAGAGGAGAACTGCGATGA	MSELTDTRWLRPCAGHWREGTGPVLLCLPHAGGGALSYAGWDRHPLGGFEPVAVCLPGREDRFAEDPVSGWAALVSAIADSLTPLAHRPLAVFGHSMGALTGYELLRELARRKRPAPLLLAVSAHRAPQEMPTAAGPPRSPRELLDYVRRLDDGGTAELLDDPEWRDLVLRPLGADLRLHDTYRSSAEPPGQPPLATPFVVLTGEDDPTVSDRTYAGWAALTHAVSARRVYPGGHFYLREQRDRLLTELGRDLENAMRGELR	MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQGLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPRSALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAFNAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAGAPSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQLFTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLGKSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA	65.17	gnl|BL_ORD_ID|342|hsp_num:0	375			81	207	enoxacin; norfloxacin
BGC0000458.1|Viomycin_9 # 18956 # 20608 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.729	BGC0000458.1|Viomycin_9 	18956	20608	+	Loose	500	29.261	OXA-919	30.91	3006105	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACGGCGATTCCGGGGAGCAGGTCACCGGCGGTCATGGACACCCCGGACGCCGCTGTCGCCCTGCTGGACACCACCAGCACGGCCCTGCGGGACGTGCTGGACCTCCATCGGATCGACCCCGAGGCCAACTTCTTCTCCCTCGGCGGGAATTCGCTGCTCGCGGTGCGGGTCGCGGGACGGCTGAGCCATGCGCTGGGTCAACGGATCCCCGCGACCGCGGTACTCAACCATCCGACGGCGCGGGGCCTGGCCCGCCACCTGGCGGAGCTGGTGTCCGAACCTGCCTCCCCCGCGTCCCCCGCCCCGCCCTCCGCTCCCGCCGATGCCACCGGCACCGACCGGTTCCCGCTCTCCGCCGCGCAGCGACGCGTCTGGCTGCTGCACGAGGTCGATCCGGAGCGGCTGGACCATCTCGTCACGGTCTCCTTCGAGGTGACCGGCGAACTCGATCCCGTGGTGGCGCGCACCGCGTGGCACCGGGTGGTCGAACGGCACGAGGCGCTGCGAACCCGGTTCGAGCCCTCCGCCCCAGGGGGTGAGGAGCCTTGCCAGGTGGTCGAGAGCGAGCCGCTGACCGAGTTCACCTTCCTGGACACCGTCCGTTTCCCCGAGGCGGTGCGCGTCCGGATCGTCGATGAGCGCGTCGCGCTCCTGCGCCGCACCCCGCTCTCCCTGCGCACCGGGCCGCTGTCCCGGATCGCCCTGCTGCGTACGGCTCCCTCGCGCTACCGGCTCGAACTGATTGTGCATCACATCGTCTGCGACGGCTGGAGCCTGGCGCTCCTGTGGCAGGACTTCCTCGACGCATACCGCCGGGTCGCGGTGGGCGAGCCGGGCCCCGGCCCCTCTCCCCATCGCTTCCGCGACCACGTCCGCTGGGAACGCCGCACCGAGTCGGCCCGATGGCCGGCGCAGGCCGACCGGGTCACCCGCCGCTTCGCCGACCGGCCGGAGGAGCTGCCGCTGCCCATCGCTCCGGCTCCCGTCGACGAGCACGACGACGGAGACGACGTCTCGCTGCCCCTGCCGGCGGGGCTGGGCACGGCGCTCGCCCGAGCGGGTGCCGAGGGTGGTCACACCCGGCTGACCCTCGCGCTGGCCGCGCTCGCCGTCCTGCTGCATCGGATCAGCGGTTCGGAGGACCTGGTGATCGCCGTACCGATGGCCGGGCGGGTGCGCCCCGAGGACGAGGGGACCGTGGGTCTCTTCGTGAACACGGCGCTTGCCAGGATCCGCCTGGCCGGGGCCCGCGACGTGCCCACGCTGGTAGCCCGCGCCAGGGACGAGGCCGCGGAGGTGCTGGACTGCCAGACGTACCCCTTCGACCAGCTCGTCAGCCGGCTCGGGGTGCCCCGCGACGGCACGCGCATGCCGCTCGCCAGGGTGTCGCTGGCCGTCCAGGACTTCGCCGAGGCCCCCCTGCCCGACCCGGATCTCGGCTTCACGTGGGTCGAGCACGATCCGGCCGAGCGACAGAGCAAGCTGGACCTGGCGTTCAGCCTGACCAGTGGCGGCGCGGCCGGACAGCCGACGCTCACCGTCACGTACCGGCCCTCACTCTTCCGCCGTCGGACCGTGGACGCCTGGGCCGAGCAGTACCTGATCGCTCTGGAGAACGTCACCCGTGCGGTGACGGGGGGTGCGTCATGA	MTAIPGSRSPAVMDTPDAAVALLDTTSTALRDVLDLHRIDPEANFFSLGGNSLLAVRVAGRLSHALGQRIPATAVLNHPTARGLARHLAELVSEPASPASPAPPSAPADATGTDRFPLSAAQRRVWLLHEVDPERLDHLVTVSFEVTGELDPVVARTAWHRVVERHEALRTRFEPSAPGGEEPCQVVESEPLTEFTFLDTVRFPEAVRVRIVDERVALLRRTPLSLRTGPLSRIALLRTAPSRYRLELIVHHIVCDGWSLALLWQDFLDAYRRVAVGEPGPGPSPHRFRDHVRWERRTESARWPAQADRVTRRFADRPEELPLPIAPAPVDEHDDGDDVSLPLPAGLGTALARAGAEGGHTRLTLALAALAVLLHRISGSEDLVIAVPMAGRVRPEDEGTVGLFVNTALARIRLAGARDVPTLVARARDEAAEVLDCQTYPFDQLVSRLGVPRDGTRMPLARVSLAVQDFAEAPLPDPDLGFTWVEHDPAERQSKLDLAFSLTSGGAAGQPTLTVTYRPSLFRRRTVDAWAEQYLIALENVTRAVTGGAS	MQRTIKAAFGLAGGTLLAMLALQGQASAAGQKLTCMIILNANSGEVIAKEGEICDKRNSPASTFKVPLALMGFESGILKDSHNPSWPYKEGYPAWRESWKQSVDPTYWEDQSVVWFSQELTRKLGKEKFQEYTDQLNYGNRDLRGDPGKNNGMLRSWISSSLTISPNEQADFLMKMVNNKLPFSEAAMTKTMAILPSHKLSNGWTAHGKTGSAFETGPKGKPDRRRQFGWYVGWAEKGDEKVVFVRLNRNMLAHNAGMGPVTRDEQWSILEKTLK	200.00	gnl|BL_ORD_ID|4140|hsp_num:0	5210			24	186	cloxacillin; oxacillin; cefalotin
BGC0000458.1|Viomycin_10 # 20605 # 21777 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGGGGG;rbs_spacer=6bp;gc_cont=0.721	BGC0000458.1|Viomycin_10 	20605	21777	+	Loose	700	26.1794	ACC-8	34.09	3006233	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam	antibiotic inactivation	ACC beta-lactamase	ATGAGGCTGGACCGACACCACGAGCTCTTCCGGACCTCGGTGCGCGCCGTGCTGGAGCGGCTCTTCCTGCCGGAGCTGGAGGACTGGGAGAAGGCGGGAGAGATGCCCACGCACGAGCTCTACCGCTCACTGGGCGAGGAGGGCCTGCTCGGGCTGACGCTGCCCGTCGACGACGGCGGCCTCGGGCTCGATCTGGGCTACTCCCACGTATGGGCGCGGGAACTCGGCAGACTCCCGGCAGGCTCCCCGGCCATGAGCCTGTCGGTGCAGACCGACATCGTGCTGCCCCTGCTCGCCGAGGAGGGCGGGACGGGCGTCCGTGACGCCTACCTCCGGTCCGCGGTACGCGGTGAGCTGGTCGCGGCCCTGGCCGCCACCGAGCCCGGCGGCGGCTCGGACCTGGCCGCCGTGCGGACCACGGCCGTACGGGACGCCGACGGACTGCGGCTGAACGGCGACAAGGCGTTCCTCACCAACGGTTCCGTGGCCGACTTCGCCGTCGTGCTCTGCCATCTCCTTCCGTCCGGGGCGGACGAGGGCGGGAACCCGCCGGACGGACTCGACTCGCTGACCCTGGTGCTGGTCCCCACCGGGCTCCCGGGCGTGCGCCAGGAACGGCACACCGGCAAACTCGGCAACCGCGCGTGCGACCACGGTCGGCTGTCCTTCACCGACGTACGTGTGCCGGAGGAGAACCTCCTGGGCAAGCCCGGCTCCGGATACGAGGCGCTGACTCGCGTCTTCACCCGCGAGCGCACCTTCCTGGCCGCGGTCTGCACGGCACGTGCCGCGACCATGCTCGACAGGGCCACCACGTACGCGCGGGGCCGGGCCGTGCTCGGCAGGCCGTTGCTCCAGCACCAGGCGATCGCCTTCCGGCTGGCCGAACTCGACGCCGAGCTGGCGCTGATCGAGCAGTACACGGACGCGGTCTTCCAGCGACTCCAGGAAGACGCCGCCGCTCTGCGGCAGGCGAGCATCGCCAAGCTCCGCGCCAGCCGGCTGGAGCGCGAGTGCGCCGATCTCCTGCTCCAACTGCACGGCGGAGCGGGCTACCTGGAAGGCGGGCCGGTCGAGCGAGGCTACCGCGACGCCCGTGCCTACGCCTTGGCCGGCGGCGCGGACGAAGCGCTGCTGCATCTGATCGCCGGTCATCCGCGGACCGACGTCTGA	MRLDRHHELFRTSVRAVLERLFLPELEDWEKAGEMPTHELYRSLGEEGLLGLTLPVDDGGLGLDLGYSHVWARELGRLPAGSPAMSLSVQTDIVLPLLAEEGGTGVRDAYLRSAVRGELVAALAATEPGGGSDLAAVRTTAVRDADGLRLNGDKAFLTNGSVADFAVVLCHLLPSGADEGGNPPDGLDSLTLVLVPTGLPGVRQERHTGKLGNRACDHGRLSFTDVRVPEENLLGKPGSGYEALTRVFTRERTFLAAVCTARAATMLDRATTYARGRAVLGRPLLQHQAIAFRLAELDAELALIEQYTDAVFQRLQEDAAALRQASIAKLRASRLERECADLLLQLHGGAGYLEGGPVERGYRDARAYALAGGADEALLHLIAGHPRTDV	MQNTLKLLSVITCLAATVQGALAANIDESKIKDTVDDLIQPLMQKNNIPGMSVAVTVNGKNYIYNYGLAAKQPQQPVTENTLFEVGSLSKTFAATLASYAQVSGKLSLDQSVSHYVPELRGSSFDHVSVLNVGTHTSGLQLFMPEDIKNTTQLMAYLKAWKPADAAGTHRVYSNIGTGLLGMIAAKSLGVSYKDAIEKTLLPQLGMHHSYLKVPADQMENYAWGYNKKDEPVHVNMEILGNEAYGIKTTSSDLLRYVQANMGQLKLDANAKMQQALTATHTGYFKSGEITQDLMWEQLPYPVSLPNLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKMGIVMLANKNYSIDQRVTVAYKILSSLEGNK	101.04	gnl|BL_ORD_ID|3097|hsp_num:0	4128			417	546	
BGC0000458.1|Viomycin_11 # 21827 # 22909 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=15bp;gc_cont=0.735	BGC0000458.1|Viomycin_11 	21827	22909	+	Loose	700	25.409	MOX-13	33.33	3006478	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam	antibiotic inactivation	MOX beta-lactamase	ATGACCATCCAAGCCGTGCCCGAACCTGCCACCAGGACGGAGCACCTGCTGTTTCTCGACCGAGCCGCCGTGCGCACCTGCGCCGCGGGCATCGACCCCGTGGCGGCCGTGGAGGACGTGCTGCGCGCCCATGCGGCGGGGCACACCGCGCTCCCCGCCGAGGGCTATCTGCCCTGGGCCAACTCCCATGGGGCGTACTGCCGTTCCATCGCGATGCTCGGCTCGGTCGGCGCCGCCGACCCGACCGTCCCGACGGCCTACGGGATGAAATTGATCAACGCCGCCACGTCCAACCCTGCCCAGGGCAGGGAGCGCGCGGGTGGGGTCAGCTTCCTGTTCGACCCCGAGACCGCGCGCCCGGCCGTCGTGGCCGAGGCCGCCTACCTGTCGGCGCTGCGCACCGGCGCGTACACCATGTCCAGCCTGCGCCACCTCGGTCCGGAGCGGTTCCAGGAAGTGACCCTCATCGGCTGCGGCGCCCAGGCGCGGACCCACGCCGAGCTGCTGGCCCGGTACTTCCCCGACGTCCGCACGCTGCATGTGCACGACCTGCTGCCGGAGCGCGCGTCCGCGTTCGCCTCCTGGGTGGAGGGCAGCGAGCTGCCGTTCACCGTGGTCCCGCACGGCCGGGCCGCCGAGGCCGCCGCGGCGAGCACGGTCGTCATCACCCTGACCATCACCGACACCGGCTATCTCTCCCCGGACCACCTGCGGCCGGGCACGTTCGTCGCCCACGTATCCCTGGACGATCTGCTGCCCGAGGTGTTCGACCGGGCGCAGGCGCTGTACGTCGACGACGTCGAGCTGGTCCGTGACAATCCGCGCCGCGTCCTGGGCCGGCTGCTGGGCGAGGGCCGGGTGCTCGCCCCCGGCACCCCGAAACCCGGGACCAGCACCATCCGCGGCACCCTCGGTGACGTCCTCACCGCGGCGGTGCCTGCCGAGCGCCCCGGCACCGGGGTCGTCGTCAGCAACCCCTTCGGGATGGCCGTCCTCGACGTCGGTCTGCTGGCCCGGGTGTACGCCCGGGCCGCCGCCGACGGCCACGGCACCCGCCTCGACCTCCTCGGAGCAGACCGGTGA	MTIQAVPEPATRTEHLLFLDRAAVRTCAAGIDPVAAVEDVLRAHAAGHTALPAEGYLPWANSHGAYCRSIAMLGSVGAADPTVPTAYGMKLINAATSNPAQGRERAGGVSFLFDPETARPAVVAEAAYLSALRTGAYTMSSLRHLGPERFQEVTLIGCGAQARTHAELLARYFPDVRTLHVHDLLPERASAFASWVEGSELPFTVVPHGRAAEAAAASTVVITLTITDTGYLSPDHLRPGTFVAHVSLDDLLPEVFDRAQALYVDDVELVRDNPRRVLGRLLGEGRVLAPGTPKPGTSTIRGTLGDVLTAAVPAERPGTGVVVSNPFGMAVLDVGLLARVYARAAADGHGTRLDLLGADR	MQQRQSILWGALATLMWAGLAHAGDKAATDPLRPVVDASIRPLLKEHRILGMAVAVLKDGKAHYFNYGVADRERAVGVSEQTLFEIGSVSKTLTATLGAYAVVQGSFELDDKASLFASWLKGSAFDNITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYANPSIGLFGYLAASSMKQPFDRLMEQTILPGLGLYHTYLNVPEQAMGHYAYGYSKEDKPIRVTPGMLADEAYGIKTSSADLLRFVKANISGVDNAAMQQAIDLTHQGQYAVGEMTQGLGWERYAYPVSEQTLLAGNSPAMIYNANPAAPAPAATGHPVLFNKTGSTNGFGAYVAFVPAKGIGIVMLANRNYPNEARIKAAHAILTQLAR	93.99	gnl|BL_ORD_ID|3704|hsp_num:0	4774			237	369	
BGC0000458.1|Viomycin_12 # 22906 # 23832 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=7bp;gc_cont=0.725	BGC0000458.1|Viomycin_12 	22906	23832	+	Loose	615	26.9498	FLC-1	26.27	3005033	protein homolog model	n/a	n/a	penam	antibiotic inactivation	FRI beta-lactamase	GTGACCGAACCCCGCGGCCTGTACTCCTTGGCCGACCTGGACGACGCGAGCGTCCAGCGCATCGTCCGCCGGACCATCGAACTCCACGCCGACCGCGACGCCCACACCCGCCCGCTGGCCGGGCTCGTCGCCGGGCTCCTCTTCACCAAGACCTCCACCCGCACCCGCACGGCGTTCACCTCGGGCGCCATCCGGCTCGGCGGGGCGCCGATCGCCTTCGGACCCACGGATCTGCAGACCAACACAGGGGAGTCCGCCGCCGACACCGGCAGGATGCTCGCCGGGATGCTCGACCTGCTCGTCGTGCGCACCGCGGGCCCGATGCGTGAACTGCGGGAGCTCTCGGGTGAGGGCGAACTCCCCGTGGTCAACGCGATGTCGGCGGAGGAGCACCCCACCCAGGGCCTGGCCGACCTGGCCACACTGATTCACCACTTCGGCGGGCTCGACGGCGTCCGTGTGCTGTACGTCGGCGAGGGCAACAACACCGCCGTCGCGCTCGCCCGGGTACTGTCCCGGCAGCCCGGCTGCCACGCCGTCTTCGCCTCTCCGGCCGGTTACAGGCTTCCGGACGCCGTGCTGGCCGAGACCGCGGCCATCGCGGATCGGCGCGGCGGCTCCGTCACCCAGGCGCACGCCCCGGGCGACGTGGTCGGCGAGGTCCACGCCGTGTACACCTCGCGCTGGCAGACGACGGGCAGTACCAAGCCCGACCCGTCCTGGCGGGACGTCTTCCGGCCCTTCCACGTCGACGCCGCGCTGATGAACCGCTGGCCGGACGCGGTGTTCCTGCACGATCTGCCCGCCCACCGGGGCGAAGAGGTCTCCGGCGAGGTGCTGGACGGCAAGTCCTCGCTGGCCTGGACGCAGGCAGGGCTGAAGGCCGCCGGCGCGATGGCCGTCCTGGAATGGGTGGTCACGACGTGA	MTEPRGLYSLADLDDASVQRIVRRTIELHADRDAHTRPLAGLVAGLLFTKTSTRTRTAFTSGAIRLGGAPIAFGPTDLQTNTGESAADTGRMLAGMLDLLVVRTAGPMRELRELSGEGELPVVNAMSAEEHPTQGLADLATLIHHFGGLDGVRVLYVGEGNNTAVALARVLSRQPGCHAVFASPAGYRLPDAVLAETAAIADRRGGSVTQAHAPGDVVGEVHAVYTSRWQTTGSTKPDPSWRDVFRPFHVDAALMNRWPDAVFLHDLPAHRGEEVSGEVLDGKSSLAWTQAGLKAAGAMAVLEWVVTT	MLKKMRKNAIILSFSLCLPFASSNSFANQERNGLAQIKELETVFGGRIGVYLLNTENGKEFSYRQNERFPLCSSFKVFLAASVLKKTQDKSFSLNDTVEYSDRVMEKHSPVSEKYLETGASVQTLAMAAIQYSDNGASNLLMERYVGGPEGLTAFMRSTGDTEFRLDRWELELNSAIPGDKRDTSTPKAVAMSLKNIAFGSVLDAKNKALLQDWLQGNTTGNARVRAAVPDKWVVGDKTGTCGFYGTANDVAILWPDSNSPAVIAVYTTRTNQNDKHDETIIKNAAKIAINAVYGSYK	103.36	gnl|BL_ORD_ID|2760|hsp_num:0	3772			51	363	
BGC0000458.1|Viomycin_13 # 23829 # 25202 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=10bp;gc_cont=0.732	BGC0000458.1|Viomycin_13 	23829	25202	+	Loose	400	27.7202	catII	30.61	3002684	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	GTGAGGACGCGGATCGCGCTCCGTACCGAGCAGGTGGCCCCGCTCTCCCCCGCCCAGTACAGCCTCTGGTTCCTCGACCAGCTCACCGGACCCTCCAGCGAGTACGTCCAGCCGTACGCGTACCGGCTGCGCGGACCGCTGGACACCTCGGCGCTGGAGGACGCCCTGAACGCGCTGGTCGAGCGGCATGAGCCGCTTCGTACGCGCGTCGACCAGGTGGCGGGCGAGCCCCGGCAGGCCGTCCGGCGCCACCACCCGCGACCGCTGCGGCGACTGGATCTCTCGCAGGACCCGGCACGGGCCGGGCGGGAGGCGGCAGCCTTCGCGCTGCGCCCTTTCGACCTGGCGGGTGAGGATCCCCTGCGCACGCTGCTCGTCCGGCTGGGCCAGCGGGACCACCTGCTGGTCTGCTCACTGCACCACATCTGCTGCGACGGGCTGTCCCTCGCGGTCCTCGGCGAGGACCTCGCCGCGCTGTACCGGGCGGCGGCGCACGGGCAGGATGTCGGACAGGCGCTGCCGCCGTTGCCGGTGCATTACCGCGACACCGTCCTCGCCCGGGCGCGGCAGGCCGACTGCCCCGCCGGGCGGCCGGCGCTGGCGCGCTGGCGCGCACGACTGGAGGGTGCCGCGCCGCTGCGGCTGCCCACCGACCGTGCCCGGCCCGAAGTCCGTACGGCGCGCGGCGACCGCGTCGAGGTCGTCGTCCCCGCCGACGTCACCTCGGCGGCTCGCGCGGCCGCGGCCCGTCACCGGGTGACCCTCTACATGGTGATGCTGTCGGTGTTCGCGATGCTGCTGCACCGCCGTGGCGGCGGCCGGGACCTCTGCGTCGGTACTCCCGTGTCCGGCCGGTCCGCCCCCGAGGAAGAGGCGCTGATCGGCCTGTTCACCAACACCGTGGTGCTCCGTCTGGACCTCTCGGACGACCGGGACCTGGCGGAACTGCTGCACCAGGTGCGCGGCCGGGCGCTGGCCGCATACCAGGACGGCCACGTCCCCTTCGAGCACGTGGTGGACGAACTGCGGCCGCCCCGCGACCTGTCACGCACCCCCGTCTTCCAGGTGATGTTCAGTTTCCAGGACTTCGAGGAGGACGCCCTGGCCCTCGACGGGCTGCGCTGCACGCCCTGGGAGATCCCGGTCGGCAGCAGCAAGTTCGACCTCGAACTCGAACTCGGCCGCGAGGGTGACCGGCTGCGCGGCTTCCTGGAGTACAGCACCGATCTGTACGAGGCCGGCACGGCCCGTGGGATGGCGGACGAGTACCTCGCCCTGCTGCGCGAGGCCCTGGGCCTCCCCGGCGACTCTCCCGGCGGAGCCGCCGATCCTGTTCGATCCTCCGATCCTTCTCCCGAGGAGCCCACACGATGA	MRTRIALRTEQVAPLSPAQYSLWFLDQLTGPSSEYVQPYAYRLRGPLDTSALEDALNALVERHEPLRTRVDQVAGEPRQAVRRHHPRPLRRLDLSQDPARAGREAAAFALRPFDLAGEDPLRTLLVRLGQRDHLLVCSLHHICCDGLSLAVLGEDLAALYRAAAHGQDVGQALPPLPVHYRDTVLARARQADCPAGRPALARWRARLEGAAPLRLPTDRARPEVRTARGDRVEVVVPADVTSAARAAAARHRVTLYMVMLSVFAMLLHRRGGGRDLCVGTPVSGRSAPEEEALIGLFTNTVVLRLDLSDDRDLAELLHQVRGRALAAYQDGHVPFEHVVDELRPPRDLSRTPVFQVMFSFQDFEEDALALDGLRCTPWEIPVGSSKFDLELELGREGDRLRGFLEYSTDLYEAGTARGMADEYLALLREALGLPGDSPGGAADPVRSSDPSPEEPTR	MNFTRIDLNTWNRREHFALYRQQIKCGFSLTTKLDITAFRTALAETDYKFYPVMIYLISRVVNQFPEFRMAMKDNALIYWDQTDPVFTVFHKETETFSALFCRYCPDISEFMAGYNAVMAEYQHNTALFPQGALPENHLNISSLPWVSFDGFNLNITGNDDYFAPVFTMAKFQQEDNRVLLPVSVQVHHAVCDGFHAARFINTLQMMCDNILK	214.55	gnl|BL_ORD_ID|1188|hsp_num:0	1295			408	555	azidamfenicol; chloramphenicol; thiamphenicol
BGC0000458.1|Viomycin_15 # 25387 # 27228 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.739	BGC0000458.1|Viomycin_15 	25387	27228	+	Loose	1000	141.354	almE	26.82	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGACCACCATGCCCACGACCGGCACGGCCGCCGACCGGAGCACCGACACCGTGCCCGCACTGCTCGCCGAGGTGGCCCGCCGCATGCCCGGCGCCCCCGCGCTCATCACCCCGGACCGGACCCTCACCCACGACGAACTCGACGACCTCACCGCGAGGTTGGCCGGCCTGCTGCGCCGGCACGGCATCGGCAGGGGGCAGCGGATCGCCGTGCTCGCCGACCGTACCTGGCAAGGGGTCTGCTGCCCGCTGGCGGTGCTGCGGGCAGGCGCCGCCTATGTGCCGCTCGACCCGTCCGATCCGGAGGACCGCCTGCGCGAGGTGGTCGCGCTCACCGGTGCGCGGGCCGTCCTCGGCCGGGCCGAGTCGCTCGGCGAGTTGCCCGGCCTCGGCATCCCCGTGATCCCCGCCGAACCGCCCGGCGACCTCGCGGGCGGGGCCCCGCCGGCCACGCGGGCCGATGCCGAGCCGCCGTTGCCGGACGACCTCGCGTACGTCATGCTCACCTCCGGCACCACCGGCACTCCCAAGGCGGTCCTGGTGCCGCACCGTGCCGTGACCCGCGCCGCCAGGTCTCTCGTCCCGCTGTTCGGCGTCACATCCACCGACCGGGTTCTGCACTGGACTTCGCTGATCTGGGACACCAGCGGCGAGGAGATCTATCCGGCTCTCCTCGGCGGTGCCGCCCTGGTGGTCGACGGACGGGTCGAGACTCGCTCCGTACCGGCCCTGCTCGCGGCGGTCCGCGAGCACCGCGTCACGGTCGTCGACCTGCCGACGGCGATGTGGAACGAGCTCGCGCACTATCTGGCCCTGGGCGGCGAGGAGTTGCCGCCCGCGCTCCGGCTGGTCGTCATCGGCGGGGAGGCGGCCCACGCCCGGACCGTACGGCTGTGGAACGAACGCGTCCCGGACCGGGTTCGCCTGCTCAACACCTACGGACAGACCGAGACCGTGATGGTGACCCACGCGGCGGAGTTGGGAGGTCCGGCGGGCCGGGCGCTGCGGGACGGCGATCCCGTGCCCATCGGCCGTCCGTTGCCCCACATCCGCCAGGTCCTGGTCCCCTCGGATGACGGGCCGGATGAGCTGTGGACCGGCGGGCCCGGCCTCGCCTGGGGATACGCCGACCGTCCCGCCCTCACCGCGGCGGCCTTCGGACCCGCCCCCGGCGCCGGCGGACGGTTCTACCGCACCGGTGACCTGGTGCGAACCCTGCCCGACGGTTCGCTCGTCCACGCGGGCCGCGCCGACCGCCGGCTCAAGGTGCGTGGGGTTCGTGTCGAACCCGCCGAGGTGGAGCGGGCGATGACGACCTGTCCGGGAGTCGTGGCCGCCGCCGTCTTCCCCGTGGGGGACGACCCGGAACACCTGCGCCTGTACGGGGCGTTCGTCCCGTCGAAGAGCGGACCCGCCACCGAGCGGGAGGTGGCGGAGCACTGTGCGCGGCGGCTACCGCGCTCCCTGCTGCCGCACCGTATCGCCGTGGTGACCGCGCTGCCCCTGCTGCGCACGGGCAAGGTCGACCGGGCGGCGCTCCAGGCTCTCTTCACCGACGCCACCACGCCCTCCGAAGGGGCGTCGGCCGGGTCCGCGTCCGGGCCGTCGCTCACCGCGCGACTCGTGGAGCTCTGCGGCCGGGCACTGGGCGCTCCGTGCGGCGCCGGCGAATCCCTCTTCGCACGGGGCGGTGACTCCCTGACCGTGACCCGCCTCATCTCGCTCGTCCATCGGGAACTGGAGACCGATCTGACGTTTCAGGACGTGTTCGACCACCCGACCCCGCAAGAACTGGCGCAGCTAGTCGAAGTCTCCGGACCCTTCCGAGGAGAGCCCCAGTGA	MTTMPTTGTAADRSTDTVPALLAEVARRMPGAPALITPDRTLTHDELDDLTARLAGLLRRHGIGRGQRIAVLADRTWQGVCCPLAVLRAGAAYVPLDPSDPEDRLREVVALTGARAVLGRAESLGELPGLGIPVIPAEPPGDLAGGAPPATRADAEPPLPDDLAYVMLTSGTTGTPKAVLVPHRAVTRAARSLVPLFGVTSTDRVLHWTSLIWDTSGEEIYPALLGGAALVVDGRVETRSVPALLAAVREHRVTVVDLPTAMWNELAHYLALGGEELPPALRLVVIGGEAAHARTVRLWNERVPDRVRLLNTYGQTETVMVTHAAELGGPAGRALRDGDPVPIGRPLPHIRQVLVPSDDGPDELWTGGPGLAWGYADRPALTAAAFGPAPGAGGRFYRTGDLVRTLPDGSLVHAGRADRRLKVRGVRVEPAEVERAMTTCPGVVAAAVFPVGDDPEHLRLYGAFVPSKSGPATEREVAEHCARRLPRSLLPHRIAVVTALPLLRTGKVDRAALQALFTDATTPSEGASAGSASGPSLTARLVELCGRALGAPCGAGESLFARGGDSLTVTRLISLVHRELETDLTFQDVFDHPTPQELAQLVEVSGPFRGEPQ	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	110.25	gnl|BL_ORD_ID|4935|hsp_num:0	5928			135	1653	colistin A; colistin B
BGC0000458.1|Viomycin_17 # 28676 # 29482 # -1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=GGGG;rbs_spacer=5bp;gc_cont=0.732	BGC0000458.1|Viomycin_17	28676	29482	-	Strict	500	525.013	vph	99.63	3003061	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic inactivation	viomycin phosphotransferase	GTGGGCGGACTCGCCGTCCACGAGGGGCAGTTCCACCATGTGGTGATCGGATCGCACCGGGTGGTCTGCTTCGCCCGCACCCGGGCGGCCGCCGACCGTCTGCCCGGCAGGGCGGACGTCCTGCGCGCTCTTGCCGGGATCGACCTCGGGTTTCGCACGCCGCAGCCGCTGTCCGAGGGCGGCGCCCAGGGCACGGACGAGCCGCCGTACCTGGTGCTGAGCCGCATTCCCGGAGCACCGTTGGAGGACGATGTGCTCACCAGCCCGGAGGTGGCGGAGGCCGTCGCCCGACAGTACGCGACCCTGCTGTCCGGGCTCGCGGCGGCGGGCGACGAGGAGAAGGTGCGCGCCGCGCTGCCGGAGGCTCCCGCGAACGAGTGGCAGGAGTTCGCCACGGGGGTGCGTACCGAACTGTTCCCGCTGATGTCCGACGGCGGCCGGGAGCGTGCCGAGCGCGAGCTCGCCGCGCTCGACGCCCTGCCCCATCTCACCTCCGCGGTGGTCCACGGTGACCTCGGCGGCGAGAACGTCCTGTGGGAGACGGTGGACGGAGTGCCGCGCATGAGCGGCGTCGTCGACTGGGACGAGGTCGGCATCGGCGACCCGGCTGAGGACCTGGCCGCCATCGGGGCGAGCTACGGCGAGGAACTGCTGGGCCGAGTGCTCGCGCTCGGCGGCTGGGCCGACAACGGAACGGCCGAGCGGATCTCGGCGATCCGAGGCACCTTCGCACTCCAGCAGGCCCTCTACGCGCAGCGCGACGGCGACGAGGAGGAACTCGCCGACGGCCTCAGCGGCTACCGGTAG	MGGLAVHEGQFHHVVIGSHRVVCFARTRAAADRLPGRADVLRALAGIDLGFRTPQPLSEGGAQGTDEPPYLVLSRIPGAPLEDDVLTSPEVAEAVARQYATLLSGLAAAGDEEKVRAALPEAPANEWQEFATGVRTELFPLMSDGGRERAERELAALDALPHLTSAVVHGDLGGENVLWETVDGVPRMSGVVDWDEVGIGDPAEDLAAIGASYGEELLGRVLALGGWADNGTAERISAIRGTFALQQALYAQRDGDEEELADGLSGYR	MRIIETHRDLLSRLLPGDTVGGLAVHEGQFHHVVIGSHRVVCFARTRAAADRLPGRADVLRALAGIDLGFRTPQPLSEGGAQGTDEPPYLVLSRIPGAPLEDDVLTSPEVAEAVARQYATLLSGLAAAGDEEKVRAALPEAPANEWQEFATGVRTELFPLMSDGGRERAERELAALDALPHLTSAVVHGDLGGENVLWETVDGVPRMSGVVDWDEVGIGDPAEDLAAIGASYGEELLGRVLALGGWADNGTAERISAIRGTFALQQALYAQRDGDEEELADGLSGYR	93.38	gnl|BL_ORD_ID|1200|hsp_num:0	1223			57	861	viomycin
BGC0000458.1|Viomycin_19 # 30660 # 31397 # -1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=5bp;gc_cont=0.690	BGC0000458.1|Viomycin_19 	30660	31397	-	Loose	390	64.3142	evgA	25.68	3000832	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGGCAGACCTCATCAGGGTGGCTCGTGCCGCATCGACCGTGCGGTGCGCCCCCGGCGGATGAGCCAGGCGCCCGGGTCCGGATCCTGTTGGCGGAGGACAGGGATGTCTATCGGGAGGGGTTGTTCGTCCTCCTCTCGGAGATCGCCAATGCCGAGGTGGTCGGCACGGCGGTGGACCGAAAGGAGTTGGTTCACCAGTCGACCCGGTTGTCGCCGGATGTCGTCGTCGCCGGAACCTCCCTGGTGCTCCCCGACGGCCTCCCTGCGCTGAGCCGGCTGCCCGAGGCTGTCTCGGGGAACACCGTCATGGCGGCCGAACGGGACACCGACGAACTGCTGTCGGCGGCGCTCGCGGCCGGGGTGCACGGCTACGTTCCGCTCAGCTCTCCGCGCGAGGACTTCGACGCGGCGATCCAGGCCGTCGCTGCCGGTGGAGGCTTCCTGCCGACCCATGTCACCCGACGTCTCGTCAGGAACTTCCATCTGGTGCCCCGCCGCACGGACAGACCGGCGGAACTGGAGCTGCTCAGCGAACGGGAGCAGCAGGTACTCCTCCTCGTCGGAGACGGACGGAGCAACCGGGAGATCGCGCGCACACTCCGGGTCAGCGAGGCCACGGTCAAGAGCCATGTCTCACGCGTCCTCGCGAAGCTCGAACTCCGCGACCGGGTCCACGCCGCCCAACTGGTGTGGCGGCTCGGCCTCGGCTCCCCGTCTCTCCTTCCGCAGACCTGA	MGQTSSGWLVPHRPCGAPPADEPGARVRILLAEDRDVYREGLFVLLSEIANAEVVGTAVDRKELVHQSTRLSPDVVVAGTSLVLPDGLPALSRLPEAVSGNTVMAAERDTDELLSAALAAGVHGYVPLSSPREDFDAAIQAVAAGGGFLPTHVTRRLVRNFHLVPRRTDRPAELELLSEREQQVLLLVGDGRSNREIARTLRVSEATVKSHVSRVLAKLELRDRVHAAQLVWRLGLGSPSLLPQT	MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG	120.10	gnl|BL_ORD_ID|936|hsp_num:0	1015			102	612	erythromycin; cloxacillin; tetracycline; oxacillin; norfloxacin
BGC0000458.1|Viomycin_20 # 31758 # 33110 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.709	BGC0000458.1|Viomycin_20 	31758	33110	+	Loose	500	27.335	TEM-193	27.96	3001053	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam; penem	antibiotic inactivation	TEM beta-lactamase	ATGAAATGCAGGGTACTGGGGAGCGCCCCTTACACGCGGCAAGCCTTGGCGGGCGCCGCACTGCTCATCGCCGGCACCGTGATGGGGCCCGCCGCAGCGTCGAGCGGAGACGAACGGGACACCTCGCGGGCACGCAACGTGATCCTGCTGGTCGGTGACGGCATGGGCGACTCCGAGATCACCCTCGCGCGCAACTACACCGTCGGCGCGGGCGGGAGGCTCCACATGGACGGTTTCCCCATGACCGGGTCGTACACCACCTACTCGGTGGACCGCGACGGACGTCCCAACTACGTCACCGACTCCGCCGCCAGCGCCACAGCCTGGGCCACCGGCCACAAGACGGTGAACGACCGGATCTCCAAGACGGCCGACACCGACCGCGCCGTGCCCACGATCCTGGAGCTCGCCCGGCAAGGCGGACTCGCCACCGGCAGCGTCACCAGCGCCGAGCTGACGGACGCCACCCCCGCCGCCCTCACCTCGCACGTCACCGACCGCAGTTGCCAGGGCCCAGCCGACATGGAGCGGTGCCCGACGGACACGCGGGCGGCGGGCGGCCCGGGCTCCATCGCCGAGCAGACGGTCGCCCACCGCGTCGACGTCCTCCTCGGCGGTGGCAGGCAACGCTTCGACCAGACCATCACCCAGGGTCCGGAGCGTGGCTCCACGGTGCTGCAGCGTGCGCGTCAGCACGGCTATCGCGTGGTGACGGACGCCAGGGGCCTGGACGCCGTCCGCCCCGGACGCCCGGTTCTGGGCCTTTTCGCACCGGAGGAGCTGCCGGTCGCCTGGACCGGAACGCCGGCCGCGGCCGGCGGCACCGCACCACAGCGCTGCGTGACCGACCGCGAACCCTCCGACGGCATCCCGAGTCTGGAGGTGCTGACGCGCAAGGCCATCGCGCTGCTGGATGCCCGAGCACGCCAGAAGGGCGCGGGGAAGGGGTTCTTCCTTCAGGTCGAAGGCGCCGCCATCGACAAGCAGAATCACGATGCCGACCCCTGCGGCCAGATCGGTGAGACCGTCGCCTTCGACCGAGCCGTCAAAGCCGCCAGGGAGTACGCCGCACGGCACCCTGACACCCTCGTCATCACCACCGCCGACCACGGGCACAGCAGTCAGATCGTGCCCATGGCGGCCAGGCCCGCAGGACTCTCCGCGACGCTGATCACGGACGAGGGCGCCCCGATGAAGGTCAGCTACGCCACGCACGCGGGCGAGGAGGGACAGGAGCACAGCGGCGTACAGGTACGCATCGCGGCCGAGGGGCCCGAGGCGCACAGAGTGCTCGGCACCACGGACCAGACCCAACTGTTCACCACTCTCCGCATCGGTCTCAACCTGCGGTGA	MKCRVLGSAPYTRQALAGAALLIAGTVMGPAAASSGDERDTSRARNVILLVGDGMGDSEITLARNYTVGAGGRLHMDGFPMTGSYTTYSVDRDGRPNYVTDSAASATAWATGHKTVNDRISKTADTDRAVPTILELARQGGLATGSVTSAELTDATPAALTSHVTDRSCQGPADMERCPTDTRAAGGPGSIAEQTVAHRVDVLLGGGRQRFDQTITQGPERGSTVLQRARQHGYRVVTDARGLDAVRPGRPVLGLFAPEELPVAWTGTPAAAGGTAPQRCVTDREPSDGIPSLEVLTRKAIALLDARARQKGAGKGFFLQVEGAAIDKQNHDADPCGQIGETVAFDRAVKAAREYAARHPDTLVITTADHGHSSQIVPMAARPAGLSATLITDEGAPMKVSYATHAGEEGQEHSGVQVRIAAEGPEAHRVLGTTDQTQLFTTLRIGLNLR	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAAHLFLTTIGGPKELTAFLHNMGDHVTRLDCWGPKLTEAIPHDERDTTMPAAVANTLRKLLTGELLTLASRQQLIDWMEADKVAGPILRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	157.34	gnl|BL_ORD_ID|1265|hsp_num:0	1380			279	555	ampicillin
BGC0000458.1|Viomycin_22 # 33717 # 36212 # -1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.738	BGC0000458.1|Viomycin_22 	33717	36212	-	Loose	1000	28.4906	tva(A)	45.45	3004730	protein homolog model	n/a	n/a	pleuromutilin antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGGCCGCCGACCGCTGCACCGTCTGGTCCGGCCGGGGAGGCGAGACCGTCACCTCCGTACCGTTCCACGTCGTACGCCAGTTGCTGCAGCCCGCCCTCGACCAGTTCCCGCCGGACGAGACCCGGGCCCTGTTCGGCGACTGGTTCGAGATCATCGCCCCGGCCCTCGGGCTGGCCGAGCCGAGCGGACCGCAGCCCGACCCGCAAGGTGTGCGCGACGGCCTGGACTACGTCGTCGGCCGGCTCGCCTCCCGGCTCAGCCACCGCCCGTTGCTGCTCATCGTGGACGACGCGCACTGGGCGGACGGTGAATCCCTCGCCTGGCTGGCCTCGTTCACCGCCCGCCTCGGTGAACTGCCGGTCCTGGTGGTGCAGGCGCACCGTCCGCAGGAGATGGCCGAACGCAACGCCGGCTACGTCGCGGACCGGGCGGCCGAGCGTGACTCCCACGGCCAGGAGAAGGTGACCCGCGTCGCGCTGCGCGCCCTGACACCGGACGCCACCGCCGTACTGGTCCGGTCGGCGCTCGGCGAGCACGCCGACGACCCGTTCTGCCGTGAGGTGTGGGCGGTGACCGGCGGCAACCCGTACGAGGCGGTCGAACTGGTCGCCAAGGTCCAGGACCACGAACTGCCGCCCGTGGAGGAGTCCGCGGGTGAACTCCGTGCGCTCGGCGCCTCCGCCCGGGGCAGCGGGCTCGTCGCCCGGCTGGAGCGGCTCGGTACGAACGCCAACCGGTTCGCCTGGGCGGCTGCCGTGCTCGGCACCGACATCTCCCAGGAACTGGCCGCCACCCTCGCCGGCATGAGCCCGGCGGAGGCCGCCGACTGCACGGCCCGGCTGCGCGACGCCCGTATCGTCAGCGGATTCGACCCGCTGGAGTTCGTCCACCCGCTGATCGCGTCCGCGGTCTACCGCTCGATCCCGTCGGCCACCCGCACCGCCATGCACGGGCGAGCCGCCTGGGCGATCACCCGGGCCGGGCTCGGGCCTGCCGCGGCCTCCAGACATCTGCTGGAGGTCCACCCGGACGACGATCAGGAGCTGGTCGCCCAACTGCGGGAAGCCGCCCGGCAGCACCTCGCCGTCGGTGCGCCCGAAGCGGCCCGGCGCTGCCTGGAACGGGCGCTGGAGGAACCGCCGCGCCCCAAGGACCGGGCGGCTCTGCTGTACGAGCTGGGCTGCGCGACCCTGCTCAGCTCACCGCCCACCACGGTCCAGCACCTGCGCGCCGCGCTGGACATGCCGGGGCTCGACGACGGACTGCGGGTCGACGCCACGTTCCGGCTCGCCGCCGCGCTCGCCCACAACAACCAGCTCAAGGAAGCGGCGCTCGCGCTGGCCGCCGAGGCCGCGCGGACCGATCCGGGCCCCGGACTGATGCGGCTCCAGGCCGCGCACTTCATGTGGGAGGGCATGCAGGCCGTCGAGGACGACGGGCCGACCCGTTCCCGCCGGCTCACCCGCAACGCCGACCACCTCAAGGGCCGTGACAACGCCGAGCGGGCACTGCTCACCCTGCGCGCCTTCGACGGCATGCTGCGCGGCGAGAACGCCCAGCTGATCGTGGACCTCTGCGAACGCGCCCTGGTCGACGGCAGCCCGGCGCGCGGGCTCGGCTGGACCGACACCGAGTGGGGCTTCGAGCTCCCCACCATGGTCGGCATCACGTACAGCTTCGTGGACCAGCTGGACCGGGCCGAGAGCCTCTTCGGCGAAGCCGTCCGGGCCTTCGAGATCTCCGGCTGGAGCGGGGCCCACCTGGCGTTCGCCCACACCCTGCTCGGCATGGTCCACCGCCGTCGCGGCCGCCTCGCGGAGGCCGAGGGCTTCCTGCGCGAGGGACTGCGCCTCGCCGACCGCGTCGGCTCCGGGCTGCCCGTGCACTGGGATGCGACGTGTCTGCTCATCGACACCCTGCTGGCCCGCGGCCGGACCGAGGAAGCACGCAGCATCGCCGACCGCTACCACTTCGGACCGCCCTACCCCAGCGCCATGGTGCTGCCGGACGGACCGTGCATCCGGGGCCGTCTGCTGCTGGCCGAGGGGCGTACGAAGGAGGCGATCGCCGAACTCGAAGCGGCGGGCGCCGCCCTGGAGGCCCGGGAACGCTTCAACGGCATCTGGGCTCCCTGGGCCGCCGACCTCGCTCGGGCCCTGGTCGACGAGGACCCGGCCCGCGCCGCTCACCTCGCCGCCCGCAACCGTGTGCACGCCGAGCGGCTCGGCACACCCACCGCCATGGGCGAGGCCCTGCGCTGTGTCGCTCTGTTCGCCCCGCCGGAGCGTTCCGCGGAACTGCTCGCCGAAGCGGTCGGCCACCTGGAGAAATCGACCTCCGGCTACGAACACGCCCTCGCCCGGTTCGAGTACGGCGCTGCGATCGGGTCGCACCGGGAGCTGGCCCGCGCGCAGAAGCAGGCGATGACCTGCGGTGCCGAGGGCCTGGCCGCCCGCGCCCAGCAGGCACGTGCGTCGATCCGGTCCTCCGAGTGA	MAADRCTVWSGRGGETVTSVPFHVVRQLLQPALDQFPPDETRALFGDWFEIIAPALGLAEPSGPQPDPQGVRDGLDYVVGRLASRLSHRPLLLIVDDAHWADGESLAWLASFTARLGELPVLVVQAHRPQEMAERNAGYVADRAAERDSHGQEKVTRVALRALTPDATAVLVRSALGEHADDPFCREVWAVTGGNPYEAVELVAKVQDHELPPVEESAGELRALGASARGSGLVARLERLGTNANRFAWAAAVLGTDISQELAATLAGMSPAEAADCTARLRDARIVSGFDPLEFVHPLIASAVYRSIPSATRTAMHGRAAWAITRAGLGPAAASRHLLEVHPDDDQELVAQLREAARQHLAVGAPEAARRCLERALEEPPRPKDRAALLYELGCATLLSSPPTTVQHLRAALDMPGLDDGLRVDATFRLAAALAHNNQLKEAALALAAEAARTDPGPGLMRLQAAHFMWEGMQAVEDDGPTRSRRLTRNADHLKGRDNAERALLTLRAFDGMLRGENAQLIVDLCERALVDGSPARGLGWTDTEWGFELPTMVGITYSFVDQLDRAESLFGEAVRAFEISGWSGAHLAFAHTLLGMVHRRRGRLAEAEGFLREGLRLADRVGSGLPVHWDATCLLIDTLLARGRTEEARSIADRYHFGPPYPSAMVLPDGPCIRGRLLLAEGRTKEAIAELEAAGAALEARERFNGIWAPWAADLARALVDEDPARAAHLAARNRVHAERLGTPTAMGEALRCVALFAPPERSAELLAEAVGHLEKSTSGYEHALARFEYGAAIGSHRELARAQKQAMTCGAEGLAARAQQARASIRSSE	MFIKFNKVSFSYDSSDNILNDVSFHIDNSCTAIVGENGCGKTTLAKLITGILKPNSGSIEYSNKNIITAYCDQECINLPDNAENLFYDDSSYSGYLTSIFKIDYNYLYRFDTLSFGERKRLQIASALYSNPDILVLDEPTNHIDIECKDILINVIKRLDCIVIIISHDIDFLDELVEKCIFIRNGNCKIRIGNYTQCRGYEKDEEDYNFSLYEESRKKAKILENRYKKLQNESDAKKSKCGSKRHIDKKDHDAKGKIDAARLAGKDSRLATKAKQAKSLYNNTVMEMESLYTKKREVMDMEFIGERYKGKFLFYLEAGETKINSIVLRHPELIVKKDSRIGIEGVNGAGKTSLLNYIIETMYDNSIDKEKIIYIPQDIDRESWNNTFNNIKALDHESLGFLMSFVNRLGSNAKSVINSLNHSPGEMRKIMLGMAVIKKPYIIMLDEPTNHLDIDSIERLEEALISFNCALIIVSHNRNFIKNAVNTLWSIKIEYNYSILDIKNTI	164.55	gnl|BL_ORD_ID|2257|hsp_num:0	3484			1179	1278	pleuromutilin
